Carrier frequency varies dramatically across populations - Tay-Sachs is 1 in 30 in Ashkenazi Jewish ancestry but 1 in 250 in the general population; cystic fibrosis is 1 in 25 in Caucasian Europeans but 1 in 94 in East Asian. This page lists population-stratified carrier rates for every gene Fulgent's Beacon panel covers, with detection rate and post-test residual risk where published.
1,314 rows · 9 populations · 1071 conditions · 135 additional panel-only genes
| Condition | Inh. | Population | Panels | ||
|---|---|---|---|---|---|
| A4GALT | Congenital disorder of glycosylation, A4GALT-related | AR | General Population | <1 in 500 | Carrier Screening |
| AAAS | Achalasia-addisonianism-alacrimia syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| AARS2 | Progressive leukoencephalopathy with ovarian failure | AR | General Population | <1 in 500 | Carrier Screening |
| ABAT | GABA-Transaminase Deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| ABCA12 | Congenital ichthyosis, ABCA12-related | AR | General Population | <1 in 500 | Carrier Screening |
| ABCA3 | Surfactant metabolism dysfunction, pulmonary 3 | AR | General Population | 1 in 116 | Carrier Screening |
| ABCA4 | Stargardt disease | AR | General Population | 1 in 51 | Carrier Screening |
| ABCA4 | Cone-rod dystrophy (ABCA4) | AR | Ashkenazi Jewish Population | 1 in 20 | Carrier Screening |
| ABCA4 | Cone-rod dystrophy (ABCA4) | AR | Middle Eastern Population | 1 in 24 | Carrier Screening |
| ABCA4 | Cone-rod dystrophy (ABCA4) | AR | South Asian Population | 1 in 36 | Carrier Screening |
| ABCA4 | Cone-rod dystrophy (ABCA4) | AR | Latino / Admixed American Population | 1 in 81 | Carrier Screening |
| ABCA4 | Cone-rod dystrophy (ABCA4) | AR | European (Non-Finnish) Population | 1 in 126 | Carrier Screening |
| ABCA4 | Cone-rod dystrophy (ABCA4) | AR | Finnish Population | 1 in 280 | Carrier Screening |
| ABCA4 | Cone-rod dystrophy (ABCA4) | AR | African / African American Population | 1 in 415 | Carrier Screening |
| ABCA4 | Cone-rod dystrophy (ABCA4) | AR | East Asian Population | 1 in 548 | Carrier Screening |
| ABCB11 | Progressive familial intrahepatic cholestasis | AR | General Population | 1 in 112 | Carrier Screening |
| ABCB4 | Progressive familial intrahepatic cholestasis | AR | General Population | <1 in 500 | Carrier Screening |
| ABCC2 | Dubin-Johnson syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| ABCC6 | Pseudoxanthoma Elasticum | AR | General Population | 1 in 79 | Carrier Screening |
| ABCC8 | Familial hyperinsulinism | AR | General Population | 1 in 112 | Carrier ScreeningNewborn |
| ABCD1 | X-linked Adrenoleukodystrophy | XL | General Population | 1 in 21,000 | Carrier ScreeningNewborn |
| ABCD4 | Methylmalonic aciduria and homocystinuria, cblJ type | AR | General Population | <1 in 500 | Carrier Screening |
| ABCG5 | Sitosterolemia 2 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| ACAD8 | Isobutyryl-CoA dehydrogenase deficiency | AR | General Population | 1 in 270 | Carrier ScreeningNewborn |
| ACAD9 | Acyl-CoA dehydrogenase-9 (ACAD9) deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| ACADM | Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency | AR | General Population | 1 in 69 | Carrier ScreeningNewborn |
| ACADS | Short-chain acyl-coA dehydrogenase (SCAD) deficiency | AR | General Population | 1 in 85 | Carrier Screening |
| ACADSB | Short branched chain acyl-CoA dehydrogenase (SBCAD) deficiency | AR | General Population | 1 in 368 | Carrier Screening |
| ACADVL | Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency | AR | General Population | 1 in 118 | Carrier ScreeningNewborn |
| ACADVL | Very long-chain acyl-CoA dehydrogenase deficiency | AR | European (Non-Finnish) Population | 1 in 161 | Carrier ScreeningNewborn |
| ACADVL | Very long-chain acyl-CoA dehydrogenase deficiency | AR | East Asian Population | 1 in 203 | Carrier ScreeningNewborn |
| ACADVL | Very long-chain acyl-CoA dehydrogenase deficiency | AR | Latino / Admixed American Population | 1 in 360 | Carrier ScreeningNewborn |
| ACADVL | Very long-chain acyl-CoA dehydrogenase deficiency | AR | Finnish Population | 1 in 411 | Carrier ScreeningNewborn |
| ACADVL | Very long-chain acyl-CoA dehydrogenase deficiency | AR | African / African American Population | 1 in 638 | Carrier ScreeningNewborn |
| ACADVL | Very long-chain acyl-CoA dehydrogenase deficiency | AR | Ashkenazi Jewish Population | 1 in 2,613 | Carrier ScreeningNewborn |
| ACAT1 | 3-ketothiolase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| ACOX1 | Peroxisomal acyl-CoA oxidase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| ACP5 | Spondyloenchondrodysplasia with immune dysregulation | AR | General Population | < 1 in 500 | Carrier Screening |
| ACSF3 | Combined malonic and methylmalonic aciduria | AR | General Population | <1 in 500 | Carrier Screening |
| ACSL4 | X-linked intellectual disability, ACSL4-related | XL | General Population | < 1 in 50,000 | Carrier Screening |
| ACVRL1 | Hereditary haemorrhagic telangiectasia type 1 | AR | European (Non-Finnish) Population | 1 in 277,994 | Newborn |
| ADA | Adenosine deaminase deficiency | AR | General Population | 1 in 224 | Carrier ScreeningNewborn |
| ADA | SCID (ADA deficiency) | AR | Latino / Admixed American Population | 1 in 508 | Carrier ScreeningNewborn |
| ADA | SCID (ADA deficiency) | AR | African / African American Population | 1 in 531 | Carrier ScreeningNewborn |
| ADA | SCID (ADA deficiency) | AR | Middle Eastern Population | 1 in 1,442 | Carrier ScreeningNewborn |
| ADA | SCID (ADA deficiency) | AR | European (Non-Finnish) Population | 1 in 3,630 | Carrier ScreeningNewborn |
| ADA | SCID (ADA deficiency) | AR | South Asian Population | 1 in 4,313 | Carrier ScreeningNewborn |
| ADA | SCID (ADA deficiency) | AR | Ashkenazi Jewish Population | 1 in 6,534 | Carrier ScreeningNewborn |
| ADA | SCID (ADA deficiency) | AR | East Asian Population | 1 in 9,925 | Carrier ScreeningNewborn |
| ADA2 | ADA2-related disorders | AR | General Population | 1 in 236 | Carrier Screening |
| ADAMTS13 | Familial Thrombotic Thrombocytopenic Purpura | AR | General Population | 1 in 77 | Carrier ScreeningNewborn |
| ADAMTS2 | Ehlers-Danlos syndrome, dermatosparaxis type | AR | General Population | <1 in 500 | Carrier Screening |
| ADAMTSL4 | ADAMTSL4-related eye disorders | AR | General Population | < 1 in 500 | Carrier Screening |
| ADGRG1 | Bilateral frontoparietal polymicrogyria | AR | General Population | <1 in 500 | Carrier Screening |
| ADGRV1 | Usher syndrome, type IIC | AR | General Population | <1 in 500 | Carrier Screening |
| ADK | Hypermethioninemia due to adenosine kinase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| AFF2 | Fragile XE syndrome | XL | General Population | <1 in 50,000 | Carrier Screening |
| AGA | Aspartylglucosaminuria | AR | General Population | <1 in 500 | Carrier Screening |
| AGL | Glycogen storage disease type III | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| AGPAT2 | Congenital generalized lipodystrophy, type 1 | AR | General Population | <1 in 500 | Carrier Screening |
| AGPS | Rhizomelic chondrodysplasia punctata, type 3 | AR | General Population | <1 in 500 | Carrier Screening |
| AGRN | Congenital myasthenic syndrome 6 | AR | General Population | <1 in 500 | Carrier Screening |
| AGXT | Primary hyperoxaluria type 1 | AR | General Population | 1 in 120 | Carrier ScreeningNewborn |
| AHCY | Hypermethioninemia due to deficiency of S-adenosylhomocysteine hydrolase | AR | General Population | <1 in 500 | Carrier Screening |
| AHI1 | Joubert syndrome, AHI1-related | AR | General Population | 1 in 448 | Carrier Screening |
| AICDA | Immunodeficiency with Hyper IgM syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| AIFM1 | AIFM1-Related Disorders | XL | General Population | < 1 in 50,000 | Carrier Screening |
| AIMP1 | Hypomyelinating leukodystrophy 3 | AR | General Population | <1 in 500 | Carrier Screening |
| AIMP2 | Hypomyelinating leukodystrophy 17 | AR | General Population | <1 in 500 | Carrier Screening |
| AIPL1 | Childhood-onset severe retinal dystrophy, AIPL1-related | AR | General Population | 1 in 409 | Carrier Screening |
| AIPL1 | AR | European (Non-Finnish) Population | 1 in 738 | Carrier Screening | |
| AIPL1 | AR | African / African American Population | 1 in 2,308 | Carrier Screening | |
| AIPL1 | AR | South Asian Population | 1 in 2,537 | Carrier Screening | |
| AIPL1 | AR | East Asian Population | 1 in 6,617 | Carrier Screening | |
| AIPL1 | AR | Finnish Population | 1 in 11,467 | Carrier Screening | |
| AIRE | Autoimmune polyendocrinopathy syndrome type I | AR | General Population | 1 in 150 | Carrier Screening |
| AK2 | Reticular dysgenesis | AR | General Population | <1 in 500 | Carrier Screening |
| AKR1D1 | Congenital Bile Acid Synthesis Defect 2 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| ALDH3A2 | Sjögren-Larsson syndrome | AR | General Population | 1 in 250 | Carrier Screening |
| ALDH4A1 | Hyperprolinemia type II | AR | General Population | <1 in 500 | Carrier Screening |
| ALDH7A1 | Pyridoxine-dependent epilepsy | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| ALDOB | Hereditary fructose intolerance | AR | General Population | 1 in 122 | Carrier ScreeningNewborn |
| ALG1 | Congenital disorder of glycosylation type Ik | AR | General Population | <1 in 500 | Carrier Screening |
| ALG12 | Congenital disorder of glycosylation type Ig | AR | General Population | <1 in 500 | Carrier Screening |
| ALG13 | ALG13-related conditions | XL | General Population | <1 in 50,000 | Carrier Screening |
| ALG3 | Congenital disorder of glycosylation type Id | AR | General Population | <1 in 500 | Carrier Screening |
| ALG5 | No carrier-frequency data published | AD | - | See gene profile → | PKD |
| ALG6 | Congenital disorder of glycosylation type Ic | AR | General Population | <1 in 500 | Carrier Screening |
| ALG9 | No carrier-frequency data published | AR | - | See gene profile → | PKD |
| ALMS1 | Alstrom syndrome | AR | General Population | 1 in 500 | Carrier Screening |
| ALOX12B | Autosomal recessive, congenital, ichthyosis 2 | AR | General Population | <1 in 500 | Carrier Screening |
| ALOXE3 | Congenital ichthyosiform erythroderma | AR | General Population | <1 in 500 | Carrier Screening |
| ALPL | Hypophosphatasia | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| AMH | Persistent mullerian duct syndrome, type I | AR | General Population | <1 in 500 | Carrier Screening |
| AMHR2 | Persistent mullerian duct syndrome, type II | AR | General Population | <1 in 500 | Carrier Screening |
| AMN | Megaloblastic anemia 1 | AR | General Population | <1 in 500 | Carrier Screening |
| AMPD2 | Pontocerebellar hypoplasia type 9 | AR | General Population | <1 in 500 | Carrier Screening |
| AMT | Glycine encephalopathy | AR | General Population | 1 in 373 | Carrier Screening |
| ANK1 | No carrier-frequency data published | AR | - | See gene profile | Newborn |
| ANO10 | Spinocerebellar ataxia 10 | AR | General Population | 1 in 93 | Carrier Screening |
| ANO5 | Limb girdle muscular dystrophy, type 2L | AR | General Population | <1 in 500 | Carrier Screening |
| ANO5 | AR | Finnish Population | 1 in 86 | Carrier Screening | |
| ANO5 | AR | Middle Eastern Population | 1 in 125 | Carrier Screening | |
| ANO5 | AR | European (Non-Finnish) Population | 1 in 156 | Carrier Screening | |
| ANO5 | AR | Latino / Admixed American Population | 1 in 429 | Carrier Screening | |
| ANO5 | AR | Ashkenazi Jewish Population | 1 in 766 | Carrier Screening | |
| ANO5 | AR | African / African American Population | 1 in 1,152 | Carrier Screening | |
| ANO5 | AR | South Asian Population | 1 in 8,609 | Carrier Screening | |
| ANTXR2 | Hyaline fibromatosis syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| AP1S1 | MEDNIK syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| AP1S2 | X-linked Intellectual disability, AP1S2-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| AP3B1 | Hermansky-Pudlak syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| AP3D1 | Hermansky-Pudlak syndrome 10 | AR | General Population | <1 in 500 | Carrier Screening |
| AP4M1 | Spastic paraplegia 50 | AR | General Population | <1 in 500 | Carrier Screening |
| APC | Familial adenomatous polyposis | European (Non-Finnish) Population | 1 in 29,242 | Cancer Screening | |
| APOPT1 | Mitochondrial complex IV deficiency | AR | General Population | <1 in 500 | |
| AQP2 | Diabetes insipidus, nephrogenic, 2 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| AR | Androgen insensitivity syndrome | XL | General Population | 1 in 14,286 | Carrier Screening |
| ARG1 | Arginase deficiency | AR | General Population | 1 in 296 | Carrier ScreeningNewborn |
| ARHGEF9 | X-linked intellectual disability, ARHGEF9-related | XL | General Population | < 1 in 50,000 | Carrier Screening |
| ARL13B | Joubert syndrome, ARL13B-related | AR | General Population | <1 in 500 | Carrier Screening |
| ARL2BP | ARL2BP-related ciliopathies | AR | General Population | <1 in 500 | Carrier Screening |
| ARL6 | ARL6-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| ARNT2 | Webb-Dattani syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| ARSA | Metachromatic leukodystrophy | AR | General Population | 1 in 100 | Carrier ScreeningNewborn |
| ARSB | Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) | AR | General Population | 1 in 250 | Carrier ScreeningNewborn |
| ARSE | Chondrodysplasia punctata type 1, X-linked | XL | General Population | 1 in 250,000 | Carrier Screening |
| ARX | X-linked intellectual disability, ARX-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| ASAH1 | ASAH1-Related Disorders | AR | General Population | <1 in 500 | Carrier Screening |
| ASL | Argininosuccinate lyase deficiency | AR | General Population | 1 in 132 | Carrier ScreeningNewborn |
| ASNS | Asparagine synthetase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| ASPA | Canavan disease | AR | General Population | 1 in 300 | Carrier Screening |
| ASS1 | Citrullinemia | AR | General Population | 1 in 119 | Carrier ScreeningNewborn |
| ASXL1 | No carrier-frequency data published | Polygenic | - | See gene profile → | KNOVA NIPT |
| ATM | Ataxia-telangiectasia | AR | General Population | 1 in 100 | Carrier ScreeningCancer Screening |
| ATM | Ataxia-telangiectasia | AR | European (Non-Finnish) Population | 1 in 591 | Carrier ScreeningCancer Screening |
| ATM | Ataxia-telangiectasia | AR | South Asian Population | 1 in 1,725 | Carrier ScreeningCancer Screening |
| ATM | Ataxia-telangiectasia | AR | East Asian Population | 1 in 6,607 | Carrier ScreeningCancer Screening |
| ATM | Ataxia-telangiectasia | AR | Latino / Admixed American Population | 1 in 7,453 | Carrier ScreeningCancer Screening |
| ATM | Ataxia-telangiectasia | AR | African / African American Population | 1 in 10,354 | Carrier ScreeningCancer Screening |
| ATM | Ataxia-telangiectasia | AR | Finnish Population | 1 in 13,355 | Carrier ScreeningCancer Screening |
| ATP13A2 | Kufor-Rakeb syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| ATP1A2 | Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies | AR | General Population | <1 in 500 | Carrier Screening |
| ATP5MD | Mitochondrial complex V deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| ATP6AP1 | Congenital disorder of glycosylation type IIs | XL | General Population | < 1 in 50,000 | Carrier Screening |
| ATP6V0A2 | Cutis laxa, type IIA | AR | General Population | <1 in 500 | Carrier Screening |
| ATP6V0A4 | Renal tubular acidosis | AR | General Population | <1 in 500 | Carrier Screening |
| ATP6V1B1 | Renal tubular acidosis with deafness | AR | General Population | <1 in 500 | Carrier Screening |
| ATP6V1E1 | Cutis laxa, type IIC | AR | General Population | <1 in 500 | Carrier Screening |
| ATP7A | Menkes disease | XL | General Population | 1 in 50,000 | Carrier ScreeningNewborn |
| ATP7B | Wilson disease | AR | General Population | 1 in 87 | Carrier ScreeningNewborn |
| ATP8A2 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4 | AR | General Population | <1 in 500 | Carrier Screening |
| ATP8B1 | Progressive familial intrahepatic cholestasis | AR | General Population | <1 in 500 | Carrier Screening |
| ATRX | No carrier-frequency data published | XL | - | See gene profile | Carrier Screening |
| AVPR2 | Nephrogenic diabetes insipidus | XL | General Population | <1 in 50,000 | Carrier ScreeningNewborn |
| AXIN2 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| B3GALT6 | Congenital disorder of glycosylation, B3GALT6-related | AR | General Population | <1 in 500 | Carrier Screening |
| B4GALT1 | Congenital disorder of glycosylation type IId | AR | General Population | <1 in 500 | Carrier Screening |
| B9D1 | Joubert syndrome 27 | AR | General Population | <1 in 500 | Carrier Screening |
| B9D2 | Meckel syndrome 10 | AR | General Population | <1 in 500 | Carrier Screening |
| BAP1 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| BARD1 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| BBS1 | Bardet-Biedl syndrome type 1 | AR | General Population | 1 in 367 | Carrier Screening |
| BBS10 | Bardet-Biedl syndrome type 10 | AR | General Population | 1 in 395 | Carrier Screening |
| BBS12 | Bardet-Biedl syndrome type 12 | AR | General Population | 1 in 791 | Carrier Screening |
| BBS2 | BBS2-related ciliopathies | AR | General Population | 1 in 621 | Carrier Screening |
| BBS4 | Bardet-Biedl syndrome 4 | AR | General Population | <1 in 500 | Carrier Screening |
| BBS5 | Bardet-Biedl syndrome 5 | AR | General Population | <1 in 500 | Carrier Screening |
| BBS7 | Bardet-Biedl syndrome 7 | AR | General Population | <1 in 500 | Carrier Screening |
| BBS9 | Bardet-Biedl syndrome 9 | AR | General Population | <1 in 500 | Carrier Screening |
| BCAP31 | Deafness, dystonia, and cerebral hypomyelination, X-linked | XL | General Population | <1 in 50,000 | Carrier Screening |
| BCHE | Butyrylcholinesterase deficiency | AR | General Population | 1 in 28 | Carrier Screening |
| BCKDHA | Maple syrup urine disease type Ia | AR | General Population | 1 in 321 | Carrier ScreeningNewborn |
| BCKDHB | Maple syrup urine disease type Ib | AR | General Population | 1 in 364 | Carrier ScreeningNewborn |
| BCS1L | Mitochondrial complex III deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| BLM | Bloom syndrome | AR | General Population | 1 in 800 | Carrier Screening |
| BLOC1S3 | Hermansky-Pudlak syndrome 8 | AR | General Population | <1 in 500 | Carrier Screening |
| BLOC1S6 | Hermansky-Pudlak syndrome 9 | AR | General Population | <1 in 500 | Carrier Screening |
| BMP1 | Osteogenesis imperfecta, type XIII | AR | General Population | <1 in 500 | Carrier Screening |
| BMPER | Diaphanospondylodysostosis | AR | General Population | <1 in 500 | Carrier Screening |
| BMPR1A | No carrier-frequency data published | AD | - | See gene profile → | Cancer ScreeningNewborn |
| BRAF | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| BRAT1 | BRAT1-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| BRCA1 | Hereditary breast and ovarian cancer syndrome | Ashkenazi Jewish Population | 1 in 95 | Cancer Screening | |
| BRCA1 | Hereditary breast and ovarian cancer syndrome | European (Non-Finnish) Population | 1 in 831 | Cancer Screening | |
| BRCA1 | Hereditary breast and ovarian cancer syndrome | South Asian Population | 1 in 845 | Cancer Screening | |
| BRCA1 | Hereditary breast and ovarian cancer syndrome | East Asian Population | 1 in 1,239 | Cancer Screening | |
| BRCA1 | Hereditary breast and ovarian cancer syndrome | Latino / Admixed American Population | 1 in 1,490 | Cancer Screening | |
| BRCA1 | Hereditary breast and ovarian cancer syndrome | African / African American Population | 1 in 2,588 | Cancer Screening | |
| BRCA1 | Hereditary breast and ovarian cancer syndrome | Finnish Population | 1 in 2,669 | Cancer Screening | |
| BRCA2 | Hereditary breast and ovarian cancer syndrome | Ashkenazi Jewish Population | 1 in 92 | Cancer Screening | |
| BRCA2 | Hereditary breast and ovarian cancer syndrome | European (Non-Finnish) Population | 1 in 345 | Cancer Screening | |
| BRCA2 | Hereditary breast and ovarian cancer syndrome | Latino / Admixed American Population | 1 in 448 | Cancer Screening | |
| BRCA2 | Hereditary breast and ovarian cancer syndrome | African / African American Population | 1 in 548 | Cancer Screening | |
| BRCA2 | Hereditary breast and ovarian cancer syndrome | East Asian Population | 1 in 599 | Cancer Screening | |
| BRCA2 | Hereditary breast and ovarian cancer syndrome | Finnish Population | 1 in 834 | Cancer Screening | |
| BRCA2 | Hereditary breast and ovarian cancer syndrome | South Asian Population | 1 in 940 | Cancer Screening | |
| BRIP1 | Fanconi anemia group J | AR | General Population | <1 in 500 | Carrier ScreeningCancer Screening |
| BRWD3 | X-linked intellectual disability, BRWD3-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| BSND | Bartter syndrome type 4a | AR | General Population | <1 in 500 | Carrier Screening |
| BTD | Biotinidase deficiency | AR | General Population | 1 in 124 | Carrier ScreeningNewborn |
| BTK | X-linked agammaglobulinemia | XL | General Population | <1 in 50,000 | Carrier ScreeningNewborn |
| C19ORF12 | Mitochondrial membrane protein- associated neurodegeneration | AR | General Population | <1 in 500 | |
| C19ORF70 | Combined oxidative phosphorylation deficiency, C19orf70-related | AR | General Population | <1 in 500 | |
| C19orf12 | No carrier-frequency data published | Various | - | See gene profile → | Carrier Screening |
| C2CD3 | Joubert Syndrome and Related Disorders, C2CD3-Related | AR | General Population | <1 in 500 | Carrier Screening |
| C8ORF37 | Bardet-Biedl Syndrome 21 | AR | General Population | <1 in 500 | |
| CAD | Early Infantile Epileptic Encephalopathy 50 | AR | General Population | <1 in 500 | Carrier Screening |
| CANT1 | Desbuquois dysplasia 1 | AR | General Population | <1 in 500 | Carrier Screening |
| CAPN3 | Limb-girdle muscular dystrophy type 2A | AR | General Population | <1 in 500 | Carrier Screening |
| CAPN3 | Limb-girdle muscular dystrophy type 2A | AR | Finnish Population | 1 in 49 | Carrier Screening |
| CAPN3 | Limb-girdle muscular dystrophy type 2A | AR | Middle Eastern Population | 1 in 160 | Carrier Screening |
| CAPN3 | Limb-girdle muscular dystrophy type 2A | AR | Ashkenazi Jewish Population | 1 in 187 | Carrier Screening |
| CAPN3 | Limb-girdle muscular dystrophy type 2A | AR | Latino / Admixed American Population | 1 in 258 | Carrier Screening |
| CAPN3 | Limb-girdle muscular dystrophy type 2A | AR | East Asian Population | 1 in 280 | Carrier Screening |
| CAPN3 | Limb-girdle muscular dystrophy type 2A | AR | African / African American Population | 1 in 441 | Carrier Screening |
| CAPN3 | Limb-girdle muscular dystrophy type 2A | AR | South Asian Population | 1 in 708 | Carrier Screening |
| CASP14 | Congenital Ichthyosis 12 | AR | General Population | <1 in 500 | Carrier Screening |
| CASQ2 | Catecholaminergic polymorphic ventricular tachycardia | AR | General Population | 1 in 224 | Carrier Screening |
| CASR | Neonatal hyperparathyroidism | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| CAVIN1 | Congenital Generalized Lipodystrophy 4 | AR | General Population | <1 in 500 | Carrier Screening |
| CBL | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| CBS | Homocystinuria due to cystathionine beta-synthase deficiency | AR | General Population | 1 in 224 | Carrier ScreeningNewborn |
| CC2D1A | Autosomal recessive intellectual developmental disorder 3 | AR | General Population | <1 in 500 | Carrier Screening |
| CC2D2A | Joubert syndrome 9 | AR | General Population | 1 in 201 | Carrier Screening |
| CCDC103 | Primary ciliary dyskinesia, type 17 | AR | General Population | 1 in 316 | Carrier Screening |
| CCDC151 | Primary ciliary dyskinesia, type 30 | AR | General Population | 1 in 365 | Carrier Screening |
| CCDC174 | Hypotonia, infantile, with psychomotor developmental delay | AR | General Population | <1 in 500 | Carrier Screening |
| CCDC39 | Primary ciliary dyskinesia, type 14 | AR | General Population | 1 in 211 | Carrier Screening |
| CCDC8 | 3-M Syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| CCDC88C | Congenital hydrocephalus 1 | AR | General Population | 1 in 137 | Carrier Screening |
| CD247 | Severe Combined Immunodeficiency | AR | General Population | <1 in 500 | Carrier Screening |
| CD3D | Severe Combined Immunodeficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| CD3E | Severe Combined Immunodeficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| CD3G | Severe Combined Immunodeficiency | AR | General Population | <1 in 500 | Carrier Screening |
| CD40 | Immunodeficiency with Hyper IgM syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| CD40LG | Hyper IgM syndrome, X-linked | XL | General Population | 1 in 50,000 | Carrier ScreeningNewborn |
| CD59 | CD59 deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| CD8A | Familial CD8 Deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| CD96 | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| CDAN1 | Dyserythropoietic congenital anemia, type Ia | AR | General Population | <1 in 500 | Carrier Screening |
| CDCA7 | Immunodeficiency-centromeric instability-facial anomalies syndrome 3 | AR | General Population | <1 in 500 | Carrier Screening |
| CDH1 | Hereditary diffuse gastric cancer | South Asian Population | 1 in 21,562 | Cancer Screening | |
| CDH1 | Hereditary diffuse gastric cancer | European (Non-Finnish) Population | 1 in 30,674 | Cancer Screening | |
| CDH23 | Usher syndrome, type 1D | AR | General Population | 1 in 285 | Carrier ScreeningNewborn |
| CDH23 | Usher syndrome type 1 | AR | East Asian Population | 1 in 196 | Carrier ScreeningNewborn |
| CDH23 | Usher syndrome type 1 | AR | African / African American Population | 1 in 1,727 | Carrier ScreeningNewborn |
| CDH23 | Usher syndrome type 1 | AR | South Asian Population | 1 in 10,746 | Carrier ScreeningNewborn |
| CDH23 | Usher syndrome type 1 | AR | European (Non-Finnish) Population | 1 in 50,520 | Carrier ScreeningNewborn |
| CDKL5 | No carrier-frequency data published | XL | - | See gene profile → | KNOVA NIPT |
| CDKN1B | No carrier-frequency data published | Various | - | See gene profile → | Cancer Screening |
| CDKN2A | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| CENPJ | CENPJ-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| CEP104 | Joubert syndrome 25 | AR | General Population | <1 in 500 | Carrier Screening |
| CEP120 | Joubert Syndrome and Related Disorders, CEP120-Related | AR | General Population | <1 in 500 | Carrier Screening |
| CEP152 | CEP152-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| CEP290 | CEP290-related Ciliopathies | AR | General Population | 1 in 190 | Carrier Screening |
| CEP41 | Joubert Syndrome and Related Disorders, CEP41-Related | AR | General Population | <1 in 500 | Carrier Screening |
| CERKL | Retinitis pigmentosa 26 | AR | General Population | 1 in 148 | Carrier Screening |
| CERS3 | Congenital ichthyosis 9 | AR | General Population | <1 in 500 | Carrier Screening |
| CFH | Complement factor H deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| CFTR | Cystic Fibrosis | AR | General Population | 1 in 32 | Carrier ScreeningNewborn |
| CFTR | Cystic fibrosis | AR | Finnish Population | 1 in 72 | Carrier ScreeningNewborn |
| CFTR | Cystic fibrosis | AR | South Asian Population | 1 in 72 | Carrier ScreeningNewborn |
| CFTR | Cystic fibrosis | AR | Middle Eastern Population | 1 in 113 | Carrier ScreeningNewborn |
| CHAT | Congenital myasthenic syndrome 6 | AR | General Population | 1 in 197 | Carrier Screening |
| CHD7 | No carrier-frequency data published | Various | - | See gene profile → | KNOVA NIPT |
| CHEK2 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| CHM | Choroideremia | XL | General Population | 1 in 25,000 | Carrier Screening |
| CHMP1A | Pontocerebellar hypoplasia type 8 | AR | General Population | <1 in 500 | Carrier Screening |
| CHRNB1 | Congenital myasthenic syndrome 2C | AR | General Population | <1 in 500 | Carrier Screening |
| CHRNE | Congenital myasthenic syndrome | AR | General Population | 1 in 408 | Carrier Screening |
| CHRNG | Multiple pterygium syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| CHST6 | Macular corneal dystrophy, CHST6-related | AR | General Population | 1 in 79 | Carrier Screening |
| CIB2 | Nonsyndromic hearing loss 48 | AR | General Population | <1 in 500 | Carrier Screening |
| CIITA | Bare lymphocyte syndrome, type II | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| CLCF1 | Crisponi cold-induced sweating syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| CLCN1 | Autosomal recessive congenital myotonia | AR | General Population | 1 in 176 | Carrier Screening |
| CLCN5 | Dent disease | XL | General Population | <1 in 500 | Carrier Screening |
| CLCNKB | Bartter syndrome type 3 | AR | General Population | <1 in 500 | Carrier Screening |
| CLN3 | Neuronal ceroid lipofuscinosis | AR | General Population | 1 in 230 | Carrier Screening |
| CLN5 | Neuronal ceroid lipofuscinosis 5 | AR | General Population | <1 in 500 | Carrier Screening |
| CLN6 | Neuronal ceroid lipofuscinosis, CLN6-related | AR | General Population | <1 in 500 | Carrier Screening |
| CLN8 | Neuronal ceroid lipofuscinosis, CLN8-related | AR | General Population | <1 in 500 | Carrier Screening |
| CLP1 | Pontocerebellar hypoplasia type 10 | AR | General Population | <1 in 500 | Carrier Screening |
| CLRN1 | Usher syndrome, type 3A | AR | General Population | 1 in 500 | Carrier Screening |
| CLRN2 | Deafness, autosomal recessive 117 | AR | General Population | < 1 in 500 | Carrier Screening |
| CNGA1 | Retinitis Pigmentosa, CNGA1-related | AR | General Population | 1 in 210 | Carrier Screening |
| CNGA3 | CNGA3-related retinopathy | AR | General Population | <1 in 500 | Carrier Screening |
| CNGB1 | Retinitis Pigmentosa, CNGB1-related | AR | General Population | 1 in 296 | Carrier Screening |
| CNGB3 | Achromatopsia | AR | General Population | 1 in 87 | Carrier Screening |
| CNTNAP2 | Cortical dysplasia-focal epilepsy syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| COA7 | Spinocerebellar ataxia with axonal neuropathy 3 | AR | General Population | <1 in 500 | Carrier Screening |
| COASY | Pontocerebellar hypoplasia type 12 | AR | General Population | <1 in 500 | Carrier Screening |
| COG5 | Congenital disorder of glycosylation type IIi | AR | General Population | <1 in 500 | Carrier Screening |
| COG6 | Congenital disorder of glycosylation type IIl | AR | General Population | <1 in 500 | Carrier Screening |
| COG7 | Congenital disorder of glycosylation type IIe | AR | General Population | <1 in 500 | Carrier Screening |
| COL10A1 | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| COL11A1 | Fibrochondrogenesis 1 | AR | General Population | <1 in 500 | Carrier ScreeningKNOVA NIPT |
| COL11A2 | COL11A2-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| COL17A1 | Junctional epidermolysis bullosa | AR | General Population | <1 in 500 | Carrier Screening |
| COL1A1 | No carrier-frequency data published | AD | - | See gene profile → | NewbornKNOVA NIPT |
| COL1A2 | No carrier-frequency data published | AD | - | See gene profile → | NewbornKNOVA NIPT |
| COL27A1 | Steel syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| COL2A1 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| COL4A3 | Alport syndrome, COL4A3-related | AR | General Population | 1 in 267 | Carrier ScreeningNewborn |
| COL4A4 | Alport syndrome, COL4A4-related | AR | General Population | 1 in 267 | Carrier ScreeningNewborn |
| COL4A5 | Alport syndrome, COL4A5-related | XL | General Population | 1 in 139 | Carrier ScreeningNewborn |
| COL6A2 | Ullrich congenital muscular dystrophy | AR | General Population | <1 in 500 | Carrier Screening |
| COL7A1 | Dystrophic epidermolysis bullosa | AR | General Population | 1 in 196 | Carrier Screening |
| COLQ | Congenital myasthenic syndrome 5 | AR | General Population | <1 in 500 | Carrier Screening |
| COQ4 | Primary Coenzyme Q10 deficiency 7 | AR | General Population | <1 in 500 | Carrier Screening |
| CORO1A | Immunodeficiency 8 | AR | General Population | <1 in 500 | Carrier Screening |
| COX10 | Mitochondrial complex IV deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| COX15 | Mitochondrial complex IV deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| COX20 | Mitochondrial complex IV deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| COX6B1 | Mitochondrial complex IV deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| CP | Aceruloplasminemia | AR | General Population | <1 in 500 | Carrier Screening |
| CPLANE1 | Joubert syndrome 17 | AR | General Population | <1 in 500 | Carrier Screening |
| CPS1 | Carbamoylphosphate synthetase I deficiency | AR | General Population | 1 in 570 | Carrier ScreeningNewborn |
| CPT1A | Carnitine palmitoyltransferase IA deficiency | AR | General Population | 1 in 354 | Carrier ScreeningNewborn |
| CPT2 | Carnitine palmitoyltransferase II deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| CRADD | Intellectual developmental disorder with variant lissencephaly | AR | General Population | 1 in 500 | Carrier Screening |
| CRB1 | CRB1-related retinopathy | AR | General Population | 1 in 104 | Carrier Screening |
| CRB2 | CRB2-related disorders | AR | General Population | < 1 in 500 | Carrier Screening |
| CRLF1 | Crisponi cold-induced sweating syndrome 1 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| CRTAP | Osteogenesis imperfecta, type VII | AR | General Population | <1 in 500 | Carrier Screening |
| CRYL1 | No carrier-frequency data published | - | See gene profile → | Carrier ScreeningNewborn | |
| CSPP1 | Joubert Syndrome and Related Disorders, CSPP1-Related | AR | General Population | <1 in 500 | Carrier Screening |
| CTC1 | Cerebroretinal microangiopathy with calcifications and cysts 1 | AR | General Population | <1 in 500 | Carrier Screening |
| CTNS | Cystinosis | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| CTPS1 | Immunodeficiency 24 | AR | General Population | <1 in 500 | Carrier Screening |
| CTSA | Galactosialidosis | AR | General Population | <1 in 500 | Carrier Screening |
| CTSC | Papillon-Lefevre syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| CTSD | Neuronal ceroid lipofuscinosis, CTSD-related | AR | General Population | <1 in 500 | Carrier Screening |
| CTSF | Neuronal ceroid lipofuscinosis 13 | AR | General Population | <1 in 500 | Carrier Screening |
| CTSK | Pycnodysostosis | AR | General Population | <1 in 500 | Carrier Screening |
| CUL4B | X-linked intellectual disability, CUL4B-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| CUL7 | 3-M syndrome 1 | AR | General Population | <1 in 500 | Carrier Screening |
| CWC27 | Retinitis pigmentosa with or without skeletal anomalies | AR | General Population | <1 in 500 | Carrier Screening |
| CYBA | Chronic granulomatous disease | AR | General Population | 1 in 224 | Carrier ScreeningNewborn |
| CYBB | Chronic granulomatous disease, X-linked | XL | General Population | 1 in 149,254 | Carrier ScreeningNewborn |
| CYP11A1 | Congenital adrenal insufficiency | AR | General Population | 1 in 114 | Carrier Screening |
| CYP11B1 | Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| CYP11B2 | Corticosterone methyloxidase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| CYP17A1 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| CYP19A1 | Aromatase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| CYP1B1 | Primary congenital glaucoma | AR | General Population | 1 in 50 | Carrier Screening |
| CYP1B1 | Primary congenital glaucoma | AR | Middle Eastern Population | 1 in 74 | Carrier Screening |
| CYP1B1 | Primary congenital glaucoma | AR | Latino / Admixed American Population | 1 in 232 | Carrier Screening |
| CYP1B1 | Primary congenital glaucoma | AR | European (Non-Finnish) Population | 1 in 263 | Carrier Screening |
| CYP1B1 | Primary congenital glaucoma | AR | East Asian Population | 1 in 496 | Carrier Screening |
| CYP1B1 | Primary congenital glaucoma | AR | South Asian Population | 1 in 636 | Carrier Screening |
| CYP1B1 | Primary congenital glaucoma | AR | Finnish Population | 1 in 1,092 | Carrier Screening |
| CYP1B1 | Primary congenital glaucoma | AR | African / African American Population | 1 in 1,220 | Carrier Screening |
| CYP1B1 | Primary congenital glaucoma | AR | Ashkenazi Jewish Population | 1 in 6,491 | Carrier Screening |
| CYP21A2 | Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (Classical/Non-Classical) | AR | General Population | 1 in 10 | Carrier Screening |
| CYP21A2 | Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (Classical) | AR | General Population | 1 in 61 | Carrier Screening |
| CYP27A1 | Cerebrotendinous xanthomatosis | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| CYP27B1 | Vitamin D–dependent rickets, type 1 | AR | General Population | 1 in 181 | Carrier ScreeningNewborn |
| CYP2C19 | No carrier-frequency data published | Polygenic | - | See gene profile → | pgx |
| CYP2D6 | No carrier-frequency data published | Polygenic | - | See gene profile → | pgx |
| CYP3A5 | No carrier-frequency data published | Polygenic | - | See gene profile → | pgx |
| CYP4F22 | Congenital ichthyosis 5 | AR | General Population | <1 in 500 | Carrier Screening |
| CYP7B1 | CYP7B1-Related Disorders | AR | General Population | <1 in 500 | Carrier Screening |
| DBT | Maple syrup urine disease, type II | AR | General Population | 1 in 481 | Carrier ScreeningNewborn |
| DCAF17 | Woodhouse-Sakati syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| DCLRE1C | Severe combined immunodeficiency with sensitivity to ionizing radiation | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| DCLRE1C | AR | Ashkenazi Jewish Population | 1 in 6,532 | Carrier ScreeningNewborn | |
| DCLRE1C | AR | African / African American Population | 1 in 6,910 | Carrier ScreeningNewborn | |
| DCLRE1C | AR | Latino / Admixed American Population | 1 in 7,432 | Carrier ScreeningNewborn | |
| DCLRE1C | AR | European (Non-Finnish) Population | 1 in 8,049 | Carrier ScreeningNewborn | |
| DCLRE1C | AR | East Asian Population | 1 in 9,923 | Carrier ScreeningNewborn | |
| DCLRE1C | AR | South Asian Population | 1 in 21,565 | Carrier ScreeningNewborn | |
| DCX | Lissencephaly, X-linked | XL | General Population | 1 in 42,500 | Carrier Screening |
| DDB2 | Xeroderma pigmentosum, group E | AR | General Population | <1 in 500 | Carrier Screening |
| DDC | Aromatic l-amino acid decarboxylase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| DDHD2 | Spastic paraplegia 54 | AR | General Population | <1 in 500 | Carrier Screening |
| DDR2 | Spondylometaepiphyseal dysplasia | AR | General Population | <1 in 500 | Carrier Screening |
| DDRGK1 | Spondyloepimetaphyseal dysplasia, Shohat type | AR | General Population | < 1 in 500 | Carrier Screening |
| DDX11 | Warsaw breakage syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| DEGS1 | Hypomyelinating leukodystrophy 18 | AR | General Population | <1 in 500 | Carrier Screening |
| DGAT1 | Diarrhea 7 (protein-losing enteropathy type) | AR | General Population | <1 in 500 | Carrier Screening |
| DGUOK | Mitochondrial DNA depletion syndrome 3 | AR | General Population | <1 in 500 | Carrier Screening |
| DHCR24 | Desmosterolosis | AR | General Population | <1 in 500 | Carrier Screening |
| DHCR7 | Smith-Lemli-Opitz syndrome | AR | General Population | 1 in 30 | Carrier Screening |
| DHDDS | Retinitis pigmentosa 59 | AR | General Population | 1 in 296 | Carrier Screening |
| DIAPH1 | Progressive microcephaly-seizures- cortical blindness-developmental delay syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| DIS3L2 | Perlman Syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| DKC1 | X-linked dyskeratosis congenita | XL | General Population | <1 in 50,000 | Carrier Screening |
| DLAT | Pyruvate dehydrogenase E2 deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| DLD | Dihydrolipoamide dehydrogenase deficiency | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| DLG3 | X-linked intellectual disability, DLG3-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| DLL3 | Spondylocostal dysostosis 1 | AR | General Population | <1 in 500 | Carrier Screening |
| DMD | Dystrophinopathies | XL | General Population | 1 in 2,350 | Carrier Screening |
| DNAH11 | Primary ciliary dyskinesia (DNAH11-related) | AR | General Population | 1 in 211 | Carrier Screening |
| DNAH5 | Primary ciliary dyskinesia, DNAH5-related | AR | General Population | 1 in 142 | Carrier Screening |
| DNAI1 | Primary ciliary dyskinesia, DNAI1-related | AR | General Population | 1 in 230 | Carrier Screening |
| DNAI2 | Primary ciliary dyskinesia, DNAI2-related | AR | General Population | 1 in 447 | Carrier Screening |
| DNAJB11 | No carrier-frequency data published | AR/AD | - | See gene profile → | PKD |
| DNAL1 | Primary ciliary dyskinesia, DNAL1-related | AR | General Population | <1 in 500 | Carrier Screening |
| DNMT3B | ICF Syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| DOCK8 | Hyper-IgE syndrome due to DOCK8 deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| DOK7 | Congenital myasthenic syndrome, DOK7-related | AR | General Population | 1 in 472 | Carrier Screening |
| DOLK | Congenital disorder of glycosylation type Im | AR | General Population | <1 in 500 | Carrier Screening |
| DPAGT1 | Congenital disorder of glycosylation type Ij | AR | General Population | <1 in 500 | Carrier Screening |
| DPYD | Dihydropyrimidine dehydrogenase deficiency | AR | General Population | <1 in 500 | Carrier Screeningpgx |
| DSE | Ehlers-Danlos syndrome, musculocontractural type 2 | AR | General Population | <1 in 500 | Carrier Screening |
| DTNBP1 | Hermansky-Pudlak syndrome 7 | AR | General Population | <1 in 500 | Carrier Screening |
| DUOX2 | Congenital hypothyroidism, DUOX2-related | AR | General Population | 1 in 56 | Carrier ScreeningNewborn |
| DUOXA2 | Congenital hypothyroidism, DUOXA2-related | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| DYNC2H1 | Short-rib thoracic dysplasia 3 with or without polydactyly | AR | General Population | 1 in 68 | Carrier Screening |
| DYSF | Limb-girdle muscular dystrophy type 2B | AR | General Population | <1 in 500 | Carrier Screening |
| DYSF | Limb-girdle muscular dystrophy type 2B (Miyoshi) | AR | African / African American Population | 1 in 290 | Carrier Screening |
| DYSF | Limb-girdle muscular dystrophy type 2B (Miyoshi) | AR | European (Non-Finnish) Population | 1 in 322 | Carrier Screening |
| DYSF | Limb-girdle muscular dystrophy type 2B (Miyoshi) | AR | Latino / Admixed American Population | 1 in 520 | Carrier Screening |
| DYSF | Limb-girdle muscular dystrophy type 2B (Miyoshi) | AR | South Asian Population | 1 in 633 | Carrier Screening |
| DYSF | Limb-girdle muscular dystrophy type 2B (Miyoshi) | AR | Ashkenazi Jewish Population | 1 in 871 | Carrier Screening |
| DYSF | Limb-girdle muscular dystrophy type 2B (Miyoshi) | AR | Finnish Population | 1 in 2,953 | Carrier Screening |
| DZIP1L | No carrier-frequency data published | AR | - | See gene profile → | PKD |
| EBP | No carrier-frequency data published | XLD | - | See gene profile → | KNOVA NIPT |
| ECEL1 | Distal arthrogryposis type 5D | AR | General Population | <1 in 500 | Carrier Screening |
| EDA | Hypohidrotic ectodermal dysplasia | XL | General Population | 1 in 14,167 | Carrier Screening |
| EFEMP2 | Cutis laxa, type 1B | AR | General Population | <1 in 500 | Carrier Screening |
| EFNB1 | No carrier-frequency data published | XLD | - | See gene profile → | KNOVA NIPT |
| EIF2AK3 | Wolcott-Rallison Syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| EIF2AK4 | Pulmonary venoocclusive disease 2 | AR | General Population | <1 in 500 | Carrier Screening |
| EIF2B1 | EIF2B1-related leukoencephalopathy with vanishing white matter | AR | General Population | <1 in 500 | Carrier Screening |
| EIF2B2 | EIF2B2-related leukoencephalopathy with vanishing white matter | AR | General Population | <1 in 500 | Carrier Screening |
| EIF2B3 | EIF2B3-related leukoencephalopathy with vanishing white matter | AR | General Population | <1 in 500 | Carrier Screening |
| EIF2B4 | EIF2B4-related leukoencephalopathy with vanishing white matter | AR | General Population | <1 in 500 | Carrier Screening |
| EIF2B5 | EIF2B5-related leukoencephalopathy with vanishing white matter | AR | General Population | <1 in 500 | Carrier Screening |
| ELANE | No carrier-frequency data published | AD | - | See gene profile | Newborn |
| ELP1 | Familial Dysautonomia | AR | General Population | 1 in 300 | Carrier Screening |
| EMD | Emery-Dreifuss muscular dystrophy | XL | General Population | 1 in 81,967 | Carrier Screening |
| EML1 | Band heterotopia | AR | General Population | <1 in 500 | Carrier Screening |
| ENG | Hereditary haemorrhagic telangiectasia type 1 | AR | European (Non-Finnish) Population | 1 in 270,694 | Newborn |
| EOGT | Adams-Oliver syndrome 4 | AR | General Population | <1 in 500 | Carrier Screening |
| EPB42 | Spherocytosis, type 5 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| EPCAM | Congenital tufting enteropathy | AR | General Population | 1 in 158 | Carrier ScreeningCancer Screening |
| EPG5 | EPG5-related disorder | AR | General Population | <1 in 500 | Carrier Screening |
| ERBB3 | ERBB3 deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| ERCC2 | ERCC2-related disorders | AR | General Population | 1 in 65 | Carrier ScreeningNewborn |
| ERCC3 | ERCC3-related photosensitivity | AR | General Population | <1 in 500 | Carrier Screening |
| ERCC4 | ERCC4-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| ERCC5 | Xeroderma Pigmentosa, group G | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| ERCC6 | ERCC6-related disorders | AR | General Population | 1 in 500 | Carrier Screening |
| ERCC6L2 | Bone marrow failure syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| ERCC8 | Cockayne syndrome type A | AR | General Population | 1 in 822 | Carrier Screening |
| ERF | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| ESCO2 | Roberts syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| ETFA | Glutaric aciduria IIA | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| ETFB | Glutaric aciduria IIB | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| ETFDH | Glutaric aciduria IIC | AR | General Population | 1 in 250 | Carrier ScreeningNewborn |
| ETHE1 | Ethylmalonic encephalopathy | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| ETHE1 | AR | Latino / Admixed American Population | 1 in 1,720 | Carrier ScreeningNewborn | |
| ETHE1 | AR | South Asian Population | 1 in 4,792 | Carrier ScreeningNewborn | |
| ETHE1 | AR | African / African American Population | 1 in 10,359 | Carrier ScreeningNewborn | |
| ETHE1 | AR | European (Non-Finnish) Population | 1 in 19,857 | Carrier ScreeningNewborn | |
| EVC | EVC-related bone growth disorders | AR | General Population | 1 in 142 | Carrier Screening |
| EVC2 | EVC2-related bone growth disorders | AR | General Population | 1 in 240 | Carrier Screening |
| EXOSC3 | Pontocerebellar hypoplasia type 1B | AR | General Population | <1 in 500 | Carrier Screening |
| EYS | Retinitis pigmentosa 25 | AR | General Population | 1 in 66 | Carrier Screening |
| F11 | Factor XI deficiency | AR | General Population | 1 in 500 | Carrier Screening |
| F2 | Prothrombin-related conditions | AR | General Population | 1 in 33 | Carrier Screening |
| F5 | Factor V deficiency | AR | General Population | 1 in 36 | Carrier Screening |
| F7 | Factor VII deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| F8 | Hemophilia A | XL | General Population | 1 in 3,250 | Carrier Screening |
| F8 | Haemophilia A | AR | European (Non-Finnish) Population | 1 in 1,298 | Carrier Screening |
| F8 | Haemophilia A | AR | Latino / Admixed American Population | 1 in 5,868 | Carrier Screening |
| F8 | Haemophilia A | AR | African / African American Population | 1 in 7,658 | Carrier Screening |
| F8 | Haemophilia A | AR | Finnish Population | 1 in 10,128 | Carrier Screening |
| F9 | Hemophilia B | XL | General Population | 1 in 15,000 | Carrier ScreeningNewborn |
| F9 | Haemophilia B | AR | European (Non-Finnish) Population | 1 in 27,770 | Carrier ScreeningNewborn |
| FA2H | Spastic paraplegia type 35 | AR | General Population | <1 in 500 | Carrier Screening |
| FAH | Tyrosinemia, type 1 | AR | General Population | 1 in 99 | Carrier ScreeningNewborn |
| FAM126A | Hypomyelinating leukodystropy type 5 | AR | General Population | <1 in 500 | Carrier Screening |
| FAM161A | Retinitis pigmentosa 28 | AR | General Population | 1 in 296 | Carrier Screening |
| FANCA | Fanconi anemia group A | AR | General Population | 1 in 239 | Carrier Screening |
| FANCB | Fanconi anemia group B | XL | General Population | <1 in 50,000 | Carrier Screening |
| FANCC | Fanconi anemia group C | AR | General Population | 1 in 535 | Carrier Screening |
| FANCD2 | Fanconi anemia, group D2 | AR | General Population | <1 in 500 | Carrier Screening |
| FANCE | Fanconi anemia, group E | AR | General Population | <1 in 500 | Carrier Screening |
| FANCF | Fanconi anemia, group F | AR | General Population | <1 in 500 | Carrier Screening |
| FANCG | Fanconi anemia group G | AR | General Population | 1 in 632 | Carrier Screening |
| FANCI | Fanconi anemia, group I | AR | General Population | <1 in 500 | Carrier Screening |
| FANCL | Fanconi anemia, group L | AR | General Population | <1 in 500 | Carrier Screening |
| FANCM | FANCM Fanconi-like genomic instability disorder | AR | General Population | <1 in 500 | Carrier Screening |
| FAT4 | FAT4-related neurodevelopmental disorder | AR | General Population | <1 in 500 | Carrier Screening |
| FBN1 | Marfan syndrome | Finnish Population | 1 in 1,567 | Newborn | |
| FBN1 | Marfan syndrome | European (Non-Finnish) Population | 1 in 32,702 | Newborn | |
| FBP1 | Fructose-1,6-bisphosphatase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| FBXL4 | Mitochondrial DNA depletion syndrome 13 | AR | General Population | <1 in 500 | Carrier Screening |
| FBXO7 | Parkinson disease 15 | AR | General Population | <1 in 500 | Carrier Screening |
| FERMT1 | Kindler syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| FGD1 | X-linked Aarskog-Scott syndrome | XL | General Population | <1 in 50,000 | Carrier Screening |
| FGFR1 | No carrier-frequency data published | Various | - | See gene profile → | KNOVA NIPT |
| FGFR2 | No carrier-frequency data published | Polygenic | - | See gene profile → | KNOVA NIPT |
| FGFR3 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| FH | Fumarase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningCancer Screening |
| FHL1 | FHL1-related neuromuscular disorders | XL | General Population | <1 in 50,000 | Carrier Screening |
| FKBP10 | Osteogenesis imperfecta type XI | AR | General Population | <1 in 500 | Carrier Screening |
| FKRP | FKRP Alpha-dystroglycanopathies | AR | General Population | 1 in 158 | Carrier Screening |
| FKTN | FKTN Alpha-dystroglycanopathies | AR | General Population | 1 in 500 | Carrier Screening |
| FLCN | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| FLNB | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| FMO3 | Trimethylaminuria | AR | General Population | 1 in 139 | Carrier Screening |
| FMR1 | Fragile X Syndrome Intermediate Allele | XL | General Population | 1 in 259 | Carrier Screening |
| FMR1 | Fragile X Syndrome Premutation | XL | General Population | 1 in 259 | Carrier Screening |
| FMR1 | Fragile X Syndrome Full Mutation | XL | General Population | 1 in 11,111 | Carrier Screening |
| FOLR1 | Cerebral folate deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| FOXI1 | FOXI1-related hearing loss | AR | General Population | <1 in 500 | Carrier Screening |
| FOXN1 | T-cell immunodeficiency with thymic aplasia | AR | General Population | <1 in 500 | Carrier Screening |
| FOXN1 | AR | European (Non-Finnish) Population | 1 in 24,161 | Carrier Screening | |
| FOXP3 | IPEX syndrome | XL | General Population | <1 in 50,000 | Carrier ScreeningNewborn |
| FOXRED1 | Mitochondrial complex I deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| FRAS1 | Fraser syndrome | AR | General Population | 1 in 250 | Carrier Screening |
| FREM1 | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| FREM2 | Fraser syndrome | AR | General Population | 1 in 354 | Carrier Screening |
| FRMD4A | Fine-Flusser syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| FRMPD4 | X-linked intellectual disability, FRMPD4-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| FRRS1L | Developmental and epileptic encephalopathy | AR | General Population | <1 in 500 | Carrier Screening |
| FTCD | Glutamate formiminotransferase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| FTSJ1 | X-linked intellectual disability, FTSJ1-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| FUCA1 | Fucosidosis | AR | General Population | <1 in 500 | Carrier Screening |
| FXN | Friedreich ataxia | AR | General Population | 1 in 80 | Carrier Screening |
| G6PC | Glycogen storage disease, type 1a | AR | General Population | 1 in 177 | Carrier ScreeningNewborn |
| G6PC3 | Severe congenital neutropenia 4 | AR | General Population | <1 in 500 | Carrier Screening |
| G6PD | Glucose-6-phosphate dehydrogenase deficiency | XL | General Population | 1 in 7 | Carrier ScreeningNewborn |
| GAA | Pompe disease | AR | General Population | 1 in 100 | Carrier ScreeningNewborn |
| GAA | Pompe disease | AR | European (Non-Finnish) Population | 1 in 53 | Carrier ScreeningNewborn |
| GAA | Pompe disease | AR | Ashkenazi Jewish Population | 1 in 90 | Carrier ScreeningNewborn |
| GAA | Pompe disease | AR | African / African American Population | 1 in 93 | Carrier ScreeningNewborn |
| GAA | Pompe disease | AR | Latino / Admixed American Population | 1 in 140 | Carrier ScreeningNewborn |
| GAA | Pompe disease | AR | South Asian Population | 1 in 153 | Carrier ScreeningNewborn |
| GAA | Pompe disease | AR | East Asian Population | 1 in 208 | Carrier ScreeningNewborn |
| GAA | Pompe disease | AR | Middle Eastern Population | 1 in 219 | Carrier ScreeningNewborn |
| GAA | Pompe disease | AR | Finnish Population | 1 in 782 | Carrier ScreeningNewborn |
| GALC | Krabbe disease | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| GALE | Galactose epimerase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| GALK1 | Galactokinase deficiency | AR | General Population | 1 in 110 | Carrier ScreeningNewborn |
| GALNS | Mucopolysaccharidosis IVA (Morquio syndrome A) | AR | General Population | 1 in 224 | Carrier ScreeningNewborn |
| GALNT3 | Familial hyperphosphatemic tumoral calcinosis | AR | General Population | <1 in 500 | Carrier Screening |
| GALT | Galactosemia | AR | General Population | 1 in 110 | Carrier ScreeningNewborn |
| GAMT | Guanidinoacetate methyltransferase deficiency | AR | General Population | 1 in 371 | Carrier ScreeningNewborn |
| GAMT | European (Non-Finnish) Population | 1 in 377 | Carrier ScreeningNewborn | ||
| GAMT | South Asian Population | 1 in 1,862 | Carrier ScreeningNewborn | ||
| GAMT | East Asian Population | 1 in 2,248 | Carrier ScreeningNewborn | ||
| GAMT | African / African American Population | 1 in 2,305 | Carrier ScreeningNewborn | ||
| GAMT | Latino / Admixed American Population | 1 in 5,590 | Carrier ScreeningNewborn | ||
| GAMT | Finnish Population | 1 in 13,175 | Carrier ScreeningNewborn | ||
| GANAB | No carrier-frequency data published | AR/AD | - | See gene profile → | PKD |
| GATC | Combined oxidative phosphorylation deficiency, GATC-related | AR | General Population | <1 in 500 | Carrier Screening |
| GATM | Cerebral creatine deficiency syndrome 3 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| GATM | Cerebral creatine deficiency (AGAT) | European (Non-Finnish) Population | 1 in 61,773 | Carrier ScreeningNewborn | |
| GBA | Gaucher disease | AR | General Population | 1 in 77 | Carrier ScreeningNewborn |
| GBE1 | Glycogen storage disease IV | AR | General Population | 1 in 387 | Carrier Screening |
| GCDH | Glutaric aciduria, type I | AR | General Population | 1 in 87 | Carrier ScreeningNewborn |
| GCH1 | Hyperphenylalaninemia (BH4-deficient, B) | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| GCSH | Glycine encephalopathy | AR | General Population | <1 in 500 | Carrier Screening |
| GDAP1 | Charcot-Marie-Tooth disease, GDAP1-related | AR | General Population | 1 in 152 | Carrier Screening |
| GDF5 | Du Pan Syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| GFM1 | Combined oxidative phosphorylation deficiency, GFM1-related | AR | General Population | <1 in 500 | Carrier Screening |
| GFPT1 | Congenital myasthenic syndrome 12 | AR | General Population | <1 in 500 | Carrier Screening |
| GH1 | Isolated growth hormone deficiency, type 1A | AR | General Population | <1 in 500 | Carrier Screening |
| GHR | Growth hormone insensitivity syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| GHRHR | Isolated growth hormone deficiency, type 1B | AR | General Population | <1 in 500 | Carrier Screening |
| GJB1 | Charcot-Marie-Tooth disease, X-linked type 1 | XL | General Population | 1 in 667 | Carrier Screening |
| GJB2 | Nonsyndromic hearing loss 1A | AR | General Population | 1 in 42 | Carrier ScreeningNewborn |
| GJB2 | Deafness (GJB2-related, mild/moderate) | AR | East Asian Population | 1 in 10 | Carrier ScreeningNewborn |
| GJB2 | Deafness (GJB2-related, mild/moderate) | AR | Finnish Population | 1 in 15 | Carrier ScreeningNewborn |
| GJB6 | No carrier-frequency data published | AR | - | See gene profile → | Carrier ScreeningNewborn |
| GJC2 | Hypomyelinating leukodystrophy 2 | AR | General Population | <1 in 500 | Carrier Screening |
| GLA | Fabry disease | XL | General Population | 1 in 25,000 | Carrier ScreeningNewborn |
| GLB1 | GLB1-related disorders | AR | General Population | 1 in 134 | Carrier ScreeningNewborn |
| GLDC | Glycine encephalopathy, GLDC-related | AR | General Population | 1 in 193 | Carrier Screening |
| GLE1 | Lethal congenital contracture syndrome 1 | AR | General Population | <1 in 500 | Carrier Screening |
| GLI3 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| GLUD1 | No carrier-frequency data published | AR | - | See gene profile | Newborn |
| GMPPA | Alacrima, achalasia, and impaired intellectual development syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| GNE | Inclusion body myopathy type 2 (Nonaka myopathy) | AR | General Population | <1 in 500 | Carrier Screening |
| GNPAT | Rhizomelic chondrodysplasia punctata, type 2 | AR | General Population | <1 in 500 | Carrier Screening |
| GNPTAB | Mucolipidosis II & III | AR | General Population | <1 in 500 | Carrier Screening |
| GNPTG | Mucolipidosis III gamma | AR | General Population | <1 in 500 | Carrier Screening |
| GNRHR | Hypogonadotropic hypogonadism, GNRHR-related | AR | General Population | 1 in 347 | Carrier Screening |
| GNS | Mucopolysaccharidosis IIID (Sanfilippo syndrome D) | AR | General Population | 1 in 500 | Carrier Screening |
| GORAB | Geroderma osteodysplasticum | AR | General Population | <1 in 500 | Carrier Screening |
| GP1BA | Bernard-Soulier syndrome type A1 | AR | General Population | 1 in 500 | Carrier Screening |
| GP1BA | Bernard-Soulier syndrome | AR | Finnish Population | 1 in 513 | Carrier Screening |
| GP1BA | Bernard-Soulier syndrome | AR | East Asian Population | 1 in 4,963 | Carrier Screening |
| GP1BA | Bernard-Soulier syndrome | AR | African / African American Population | 1 in 5,170 | Carrier Screening |
| GP1BA | Bernard-Soulier syndrome | AR | Latino / Admixed American Population | 1 in 5,591 | Carrier Screening |
| GP1BA | Bernard-Soulier syndrome | AR | European (Non-Finnish) Population | 1 in 9,422 | Carrier Screening |
| GP9 | Bernard-Soulier syndrome type C | AR | General Population | 1 in 500 | Carrier Screening |
| GP9 | Bernard-Soulier syndrome | AR | Finnish Population | 1 in 320 | Carrier Screening |
| GP9 | Bernard-Soulier syndrome | AR | European (Non-Finnish) Population | 1 in 589 | Carrier Screening |
| GP9 | Bernard-Soulier syndrome | AR | South Asian Population | 1 in 730 | Carrier Screening |
| GP9 | Bernard-Soulier syndrome | AR | African / African American Population | 1 in 1,295 | Carrier Screening |
| GP9 | Bernard-Soulier syndrome | AR | East Asian Population | 1 in 3,308 | Carrier Screening |
| GP9 | Bernard-Soulier syndrome | AR | Latino / Admixed American Population | 1 in 5,589 | Carrier Screening |
| GPHN | Molybdenum cofactor deficiency C | AR | General Population | <1 in 500 | Carrier Screening |
| GPR143 | X-linked Ocular albinism, GPR143-related | XL | General Population | 1 in 25,000 | Carrier ScreeningNewborn |
| GREM1 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| GRHPR | Primary hyperoxaluria type II | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| GRIP1 | Fraser syndrome | AR | General Population | 1 in 84 | Carrier Screening |
| GSS | Glutathione synthetase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| GUCY2D | Leber congenital amaurosis 1 | AR | General Population | <1 in 500 | Carrier Screening |
| GUCY2D | Leber congenital amaurosis (GUCY2D) | AR | Finnish Population | 1 in 121 | Carrier Screening |
| GUCY2D | Leber congenital amaurosis (GUCY2D) | AR | European (Non-Finnish) Population | 1 in 604 | Carrier Screening |
| GUCY2D | Leber congenital amaurosis (GUCY2D) | AR | African / African American Population | 1 in 2,960 | Carrier Screening |
| GUCY2D | Leber congenital amaurosis (GUCY2D) | AR | Latino / Admixed American Population | 1 in 3,176 | Carrier Screening |
| GUCY2D | Leber congenital amaurosis (GUCY2D) | AR | South Asian Population | 1 in 7,171 | Carrier Screening |
| GUCY2D | Leber congenital amaurosis (GUCY2D) | AR | East Asian Population | 1 in 9,924 | Carrier Screening |
| GUSB | Mucopolysaccharidosis type VII | AR | General Population | 1 in 250 | Carrier ScreeningNewborn |
| GYS2 | Glycogen storage disease, type 0, liver | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HADH | Familial hyperinsulinemic hypoglycemia 4 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HADHA | HADHA-related long-chain hydroxyacyl-CoA dehydrogenase and trifunctional protein deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HADHB | HADHB-related trifunctional protein deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HAMP | Hemochromatosis, type 2B | AR | General Population | <1 in 500 | Carrier Screening |
| HAX1 | Severe congenital neutropenia, HAX1-related | AR | General Population | 1 in 224 | Carrier ScreeningNewborn |
| HBA1 | No carrier-frequency data published | AR | - | See gene profile | Carrier Screening |
| HBA2 | No carrier-frequency data published | AR | - | See gene profile → | Carrier Screening |
| HBB | Hemoglobin E thalassemia | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| HBB | Sickle cell disease | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| HBB | Beta thalassemia | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| HBB | Hemoglobin C disease | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| HBD | No carrier-frequency data published | - | See gene profile | Carrier Screening | |
| HCFC1 | Methylmalonic acidemia with homocystinuria, type cblX | XL | General Population | <1 in 50,000 | Carrier Screening |
| HDAC8 | No carrier-frequency data published | AR | - | See gene profile → | KNOVA NIPT |
| HELLS | Immunodeficiency, Centromeric region instability, Facial anomalies syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| HEXA | Tay-Sachs disease | AR | General Population | 1 in 300 | Carrier Screening |
| HEXB | Sandhoff disease | AR | General Population | 1 in 600 | Carrier Screening |
| HFE | Hereditary Hemochromatosis | AR | General Population | 1 in 10 | Carrier Screening |
| HGD | Alkaptonuria | AR | General Population | 1 in 250 | Carrier Screening |
| HGSNAT | Mucopolysaccharidosis type IIIC (Sanfilippo syndrome C) | AR | General Population | 1 in 434 | Carrier Screening |
| HIKESHI | Hypomyelinating leukodystrophy 13 | AR | General Population | <1 in 500 | Carrier Screening |
| HINT1 | Neuromyotonia and axonal neuropathy | AR | General Population | <1 in 500 | Carrier Screening |
| HJV | Hemochromatosis, type 2A | AR | General Population | 1 in 500 | Carrier Screening |
| HLCS | Holocarboxylase synthetase deficiency | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| HMGCL | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HMOX1 | Heme oxygenase-1 deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| HNF4A | MODY1 (HNF4A diabetes) | European (Non-Finnish) Population | 1 in 2,224 | Newborn | |
| HNF4A | MODY1 (HNF4A diabetes) | Latino / Admixed American Population | 1 in 2,235 | Newborn | |
| HNF4A | MODY1 (HNF4A diabetes) | South Asian Population | 1 in 14,370 | Newborn | |
| HNRNPH2 | X-linked intellectual disability, HNRNPH2-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| HNRNPK | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| HOGA1 | Primary hyperoxaluria type III | AR | General Population | 1 in 184 | Carrier ScreeningNewborn |
| HOXB13 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| HPD | Tyrosinemia type III | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HPRT1 | HPRT1-related disorders: Lesch- Nyhan syndrome and Kelley- Seegmiller syndrome | XL | General Population | <1 in 50,000 | Carrier Screening |
| HPS1 | Hermansky-Pudlak syndrome 1 | AR | General Population | 1 in 354 | Carrier ScreeningNewborn |
| HPS3 | Hermansky-Pudlak syndrome 3 | AR | General Population | 1 in 354 | Carrier Screening |
| HPS4 | Hermansky-Pudlak syndrome 4 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HPS5 | Hermansky-Pudlak syndrome 5 | AR | General Population | <1 in 500 | Carrier Screening |
| HPS6 | Hermansky-Pudlak syndrome 6 | AR | General Population | <1 in 500 | Carrier Screening |
| HRAS | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| HSD17B10 | HSD10 mitochondrial disease | XL | General Population | <1 in 50,000 | Carrier Screening |
| HSD17B3 | 17-Beta-Hydroxysteroid Dehydrogenase Deficiency | AR | General Population | 1 in 192 | Carrier Screening |
| HSD17B4 | D-bifunctional protein deficiency | AR | General Population | 1 in 158 | Carrier Screening |
| HSD3B2 | Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HSD3B7 | Congenital bile acid synthesis defect 1 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| HSPD1 | Hypomyelinating leukodystrophy 4 | AR | General Population | <1 in 500 | Carrier Screening |
| HYAL1 | Mucopolysaccharidosis type IX | AR | General Population | <1 in 500 | Carrier Screening |
| HYLS1 | Hydrolethalus syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| IDH3B | Retinitis pigmentosa, IDH3B- related | AR | General Population | 1 in 296 | Carrier Screening |
| IDS | Mucopolysaccharidosis type II (Hunter syndrome) | XL | General Population | 1 in 50,000 | Carrier ScreeningNewborn |
| IDUA | Mucopolysaccharidosis, type I (Hurler syndrome) | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| IDUA | Mucopolysaccharidosis type I (Hurler) | AR | Finnish Population | 1 in 182 | Carrier ScreeningNewborn |
| IDUA | Mucopolysaccharidosis type I (Hurler) | AR | Latino / Admixed American Population | 1 in 542 | Carrier ScreeningNewborn |
| IDUA | Mucopolysaccharidosis type I (Hurler) | AR | East Asian Population | 1 in 661 | Carrier ScreeningNewborn |
| IDUA | Mucopolysaccharidosis type I (Hurler) | AR | African / African American Population | 1 in 826 | Carrier ScreeningNewborn |
| IDUA | Mucopolysaccharidosis type I (Hurler) | AR | South Asian Population | 1 in 1,465 | Carrier ScreeningNewborn |
| IDUA | Mucopolysaccharidosis type I (Hurler) | AR | Ashkenazi Jewish Population | 1 in 2,095 | Carrier ScreeningNewborn |
| IFNAR1 | Immunodeficiency 106 | AR | General Population | <1 in 500 | Carrier Screening |
| IFT140 | IFT140-related disorders | AR | General Population | <1 in 500 | Carrier ScreeningPKD |
| IFT172 | IFT172-related ciliopathies | AR | General Population | <1 in 500 | Carrier Screening |
| IFT27 | IFT27-related ciliopathies | AR | General Population | <1 in 500 | Carrier Screening |
| IGHMBP2 | IGHMBP2-related neuropathies | AR | General Population | <1 in 500 | Carrier Screening |
| IGSF1 | X-linked central hypothyroidism and testicular enlargement | XL | General Population | <1 in 50,000 | Carrier ScreeningNewborn |
| IKBKB | Immunodeficiency 15B | AR | General Population | <1 in 500 | Carrier Screening |
| IL10RA | Inflammatory bowel disease 28 | AR | General Population | <1 in 500 | Carrier Screening |
| IL1RAPL1 | X-linked intellectual disability, IL1RAPL1-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| IL2RA | Immunodeficiency due to CD25 deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| IL2RG | X-linked severe combined immunodeficiency | XL | General Population | 1 in 25,000 | Carrier ScreeningNewborn |
| IL7R | Severe Combined Immunodeficiency 104 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| IL7R | Multiple sclerosis | AR | Latino / Admixed American Population | 1 in 1,719 | Carrier ScreeningNewborn |
| IL7R | Multiple sclerosis | AR | European (Non-Finnish) Population | 1 in 3,020 | Carrier ScreeningNewborn |
| IL7R | Multiple sclerosis | AR | East Asian Population | 1 in 9,925 | Carrier ScreeningNewborn |
| IL7R | Multiple sclerosis | AR | South Asian Population | 1 in 21,562 | Carrier ScreeningNewborn |
| INPP5E | Joubert syndrome 1 | AR | General Population | 1 in 159 | Carrier Screening |
| INS | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| INSR | INSR-related conditions | AR | General Population | <1 in 500 | Carrier Screening |
| INVS | Nephronophthisis 2 | AR | General Population | <1 in 500 | Carrier Screening |
| IQCB1 | Senior-Loken Syndrome 5, IQCB1-Related | AR | General Population | <1 in 500 | Carrier Screening |
| ISPD | Muscular Dystrophy- Dystroglycanopathy, ISPD-Related | AR | General Population | 1 in 371 | Carrier Screening |
| ITGA2B | Glanzmann thrombasthenia | AR | General Population | <1 in 500 | Carrier Screening |
| ITGA2B | Glanzmann thrombasthenia | AR | East Asian Population | 1 in 579 | Carrier Screening |
| ITGA2B | Glanzmann thrombasthenia | AR | South Asian Population | 1 in 1,101 | Carrier Screening |
| ITGA2B | Glanzmann thrombasthenia | AR | European (Non-Finnish) Population | 1 in 1,747 | Carrier Screening |
| ITGA2B | Glanzmann thrombasthenia | AR | African / African American Population | 1 in 1,805 | Carrier Screening |
| ITGA2B | Glanzmann thrombasthenia | AR | Latino / Admixed American Population | 1 in 3,190 | Carrier Screening |
| ITGA6 | Junctional epidermolysis bullosa | AR | General Population | <1 in 500 | Carrier Screening |
| ITGB3 | Glanzmann thrombasthenia | AR | General Population | <1 in 500 | Carrier Screening |
| ITGB3 | Glanzmann thrombasthenia | AR | East Asian Population | 1 in 709 | Carrier Screening |
| ITGB3 | Glanzmann thrombasthenia | AR | African / African American Population | 1 in 799 | Carrier Screening |
| ITGB3 | Glanzmann thrombasthenia | AR | Latino / Admixed American Population | 1 in 894 | Carrier Screening |
| ITGB3 | Glanzmann thrombasthenia | AR | European (Non-Finnish) Population | 1 in 1,637 | Carrier Screening |
| ITGB3 | Glanzmann thrombasthenia | AR | South Asian Population | 1 in 1,875 | Carrier Screening |
| ITGB4 | Junctional epidermolysis bullosa | AR | General Population | <1 in 500 | Carrier Screening |
| ITPA | Developmental and epileptic encephalopathy 35 | AR | General Population | <1 in 500 | Carrier Screening |
| ITPR1 | ITPR1-related conditions | AR | General Population | <1 in 500 | Carrier Screening |
| IVD | Isovaleric Acidemia | AR | General Population | 1 in 167 | Carrier ScreeningNewborn |
| IYD | Thyroid dyshormonogenesis, IYD-related | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| JAG1 | No carrier-frequency data published | AD | - | See gene profile | Newborn |
| JAK3 | Severe combined immunodeficiency, JAK3-related | AR | General Population | 1 in 299 | Carrier ScreeningNewborn |
| JAK3 | AR | Middle Eastern Population | 1 in 1,145 | Carrier ScreeningNewborn | |
| JAK3 | AR | European (Non-Finnish) Population | 1 in 9,572 | Carrier ScreeningNewborn | |
| JAK3 | AR | South Asian Population | 1 in 10,522 | Carrier ScreeningNewborn | |
| KAT6B | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| KCNE1 | No carrier-frequency data published | AD | - | See gene profile | Newborn |
| KCNJ1 | Bartter syndrome type 2 | AR | General Population | <1 in 500 | Carrier Screening |
| KCNJ10 | SeSAME syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| KCNJ11 | KCNJ11-related hyperinsulinism | AR | General Population | 1 in 423 | Carrier ScreeningNewborn |
| KCNQ2 | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| KCTD7 | Progressive myoclonic epilepsy type 3 | AR | General Population | <1 in 500 | Carrier Screening |
| KDM5C | X-linked intellectual disability, KDM5C-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| KIAA0586 | KIAA0586-related conditions | AR | General Population | <1 in 500 | Carrier Screening |
| KIF14 | Primary Autosomal Recessive Microcephaly 20 | AR | General Population | <1 in 500 | Carrier Screening |
| KMT2D | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| KPTN | KPTN-related intellectual disability | AR | General Population | <1 in 500 | Carrier Screening |
| KRAS | Linear sebaceous naevus syndrome | European (Non-Finnish) Population | 1 in 277,817 | KNOVA NIPT | |
| KRT14 | Epidermolysis bullosa simplex 1D | AR | General Population | <1 in 500 | Carrier Screening |
| KY | Myofibrillar myopathy 7 | AR | General Population | <1 in 500 | Carrier Screening |
| L1CAM | L1 syndrome | XL | General Population | 1 in 15,000 | Carrier Screening |
| LAMA2 | Muscular dystrophy, LAMA2-related | AR | General Population | <1 in 500 | Carrier Screening |
| LAMA3 | Junctional epidermolysis bullosa 2 | AR | General Population | 1 in 781 | Carrier Screening |
| LAMB3 | Junctional epidermolysis bullosa, LAMB3-related | AR | General Population | 1 in 781 | Carrier Screening |
| LAMC2 | Junctional epidermolysis bullosa, LAMC2-related | AR | General Population | 1 in 781 | Carrier Screening |
| LAMP2 | Danon disease | XL | General Population | 1 in 16,700 | Carrier ScreeningNewborn |
| LARGE1 | Muscular dystrophy- dystroglycanopathy (LARGE1-related) | AR | General Population | <1 in 500 | Carrier Screening |
| LARP7 | Alazami syndrome | AR | General Population | < 1 in 500 | Carrier Screening |
| LARS | Infantile liver failure syndrome 1 | AR | General Population | <1 in 500 | |
| LCA5 | Leber congenital amaurosis 5 | AR | General Population | 1 in 500 | Carrier Screening |
| LCK | Immunodeficiency 22 | AR | General Population | <1 in 500 | Carrier Screening |
| LDLR | Familial hypercholesterolemia | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| LDLR | Familial hypercholesterolaemia | South Asian Population | 1 in 339 | Carrier ScreeningNewborn | |
| LDLR | Familial hypercholesterolaemia | East Asian Population | 1 in 376 | Carrier ScreeningNewborn | |
| LDLR | Familial hypercholesterolaemia | European (Non-Finnish) Population | 1 in 459 | Carrier ScreeningNewborn | |
| LDLR | Familial hypercholesterolaemia | Latino / Admixed American Population | 1 in 699 | Carrier ScreeningNewborn | |
| LDLR | Familial hypercholesterolaemia | Ashkenazi Jewish Population | 1 in 708 | Carrier ScreeningNewborn | |
| LDLR | Familial hypercholesterolaemia | African / African American Population | 1 in 829 | Carrier ScreeningNewborn | |
| LDLR | Familial hypercholesterolaemia | Finnish Population | 1 in 1,046 | Carrier ScreeningNewborn | |
| LDLRAP1 | Familial Hypercholesterolemia | AR | General Population | <1 in 500 | Carrier Screening |
| LHCGR | Leydig cell hypoplasia | AR | General Population | <1 in 500 | Carrier Screening |
| LHX3 | Combined pituitary hormone deficiency 3 | AR | General Population | 1 in 45 | Carrier ScreeningNewborn |
| LIFR | Stuve-Wiedemann syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| LIG4 | LIG4 syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| LIPA | Lysosomal acid lipase deficiency | AR | General Population | 1 in 211 | Carrier ScreeningNewborn |
| LIPH | Hypotrichosis 7 | AR | General Population | <1 in 500 | Carrier Screening |
| LIPN | Congenital Ichthyosis 8 | AR | General Population | <1 in 500 | Carrier Screening |
| LMAN1 | Combined factor V and VIII deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| LMBRD1 | Methylmalonic aciduria and homocystinuria, cblF type | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| LMNA | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| LONP1 | CODAS syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| LOXHD1 | Nonsyndromic hearing loss 77 | AR | General Population | 1 in 500 | Carrier Screening |
| LPAR6 | Hypotrichosis 8 | AR | General Population | <1 in 500 | Carrier Screening |
| LPL | Familial lipoprotein lipase deficiency | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| LRAT | Leber congenital amaurosis 14 | AR | General Population | <1 in 500 | Carrier Screening |
| LRBA | Combined immunodeficiency, LRBA-related | AR | General Population | <1 in 500 | Carrier Screening |
| LRP2 | Donnai–Barrow syndrome | AR | General Population | 1 in 214 | Carrier Screening |
| LRPPRC | Leigh syndrome with Complex IV deficiency | AR | General Population | 1 in 447 | Carrier Screening |
| LTBP3 | Dental anomalies and short stature | AR | General Population | <1 in 500 | Carrier Screening |
| LTBP4 | Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities | AR | General Population | <1 in 500 | Carrier Screening |
| LYST | Chediak-Higashi syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| MADD | DEEAH syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| MAK | Retinitis Pigmentosa 62 | AR | General Population | <1 in 500 | Carrier Screening |
| MALT1 | Immunodeficiency 12 | AR | General Population | <1 in 500 | Carrier Screening |
| MAN1B1 | Rafiq syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| MAN2B1 | Alpha-Mannosidosis | AR | General Population | 1 in 354 | Carrier Screening |
| MANBA | Beta-Mannosidosis | AR | General Population | <1 in 500 | Carrier Screening |
| MAP2K1 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| MAP2K2 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| MAT1A | Methionine adenosyltransferase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| MAX | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| MBD4 | No carrier-frequency data published | AR | - | See gene profile → | Cancer Screening |
| MBTPS2 | MBTPS2-related disorders (X-linked) | XL | General Population | <1 in 50,000 | Carrier Screening |
| MC2R | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| MCCC1 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency (3-MCC deficiency) | AR | General Population | 1 in 95 | Carrier ScreeningNewborn |
| MCCC2 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency (3-MCC deficiency) | AR | General Population | 1 in 95 | Carrier ScreeningNewborn |
| MCEE | Methylmalonyl-CoA epimerase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| MCOLN1 | Mucolipidosis IV | AR | General Population | 1 in 300 | Carrier Screening |
| MCPH1 | Primary microcephaly 1, recessive | AR | General Population | 1 in 147 | Carrier Screening |
| MECP2 | MECP2-related conditions | XL | General Population | <1 in 50,000 | Carrier ScreeningKNOVA NIPT |
| MECP2 | Rett syndrome | XL | European (Non-Finnish) Population | 1 in 42,101 | Carrier ScreeningKNOVA NIPT |
| MECR | MECR-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| MED17 | Postnatal Progressive Microcephaly with Seizures and Brain Atrophy | AR | General Population | <1 in 500 | Carrier Screening |
| MED25 | Basel-Vanagaite-Smirin-Yosef syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| MEFV | Familial Mediterranean fever | AR | General Population | 1 in 20 | Carrier ScreeningNewborn |
| MEGF8 | Carpenter syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| MEN1 | No carrier-frequency data published | AD | - | See gene profile → | Cancer ScreeningNewborn |
| MESP2 | Spondylocostal dysostosis | AR | General Population | <1 in 500 | Carrier Screening |
| MET | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| MFSD8 | Neuronal ceroid lipofuscinosis, MFSD8-related | AR | General Population | <1 in 500 | Carrier Screening |
| MGP | Keutel syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| MID1 | Opitz GBBB syndrome, type I | XL | General Population | <1 in 50,000 | Carrier Screening |
| MKKS | Bardet-Biedl syndrome 6 | AR | General Population | <1 in 500 | Carrier Screening |
| MKS1 | MKS1-related ciliopathies | AR | General Population | 1 in 260 | Carrier Screening |
| MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts | AR | General Population | <1 in 500 | Carrier Screening |
| MLH1 | Constitutional mismatch repair deficiency | African / African American Population | 1 in 3,590 | Cancer Screening | |
| MLH1 | Constitutional mismatch repair deficiency | South Asian Population | 1 in 3,698 | Cancer Screening | |
| MLH1 | Constitutional mismatch repair deficiency | European (Non-Finnish) Population | 1 in 4,569 | Cancer Screening | |
| MLH1 | Constitutional mismatch repair deficiency | Latino / Admixed American Population | 1 in 5,591 | Cancer Screening | |
| MLH1 | Constitutional mismatch repair deficiency | Finnish Population | 1 in 6,675 | Cancer Screening | |
| MLH3 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| MLYCD | Malonyl-CoA decarboxylase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| MMAA | Methylmalonic aciduria, cblA type | AR | General Population | 1 in 301 | Carrier ScreeningNewborn |
| MMAB | Methylmalonic aciduria, cblB type | AR | General Population | 1 in 435 | Carrier ScreeningNewborn |
| MMACHC | Methylmalonic aciduria and homocystinuria, cblC type | AR | General Population | 1 in 134 | Carrier ScreeningNewborn |
| MMADHC | Methylmalonic aciduria and homocystinuria, cblD type | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| MOCS1 | Molybdenum cofactor deficiency A | AR | General Population | <1 in 500 | Carrier Screening |
| MOCS2 | Molybdenum cofactor deficiency B | AR | General Population | <1 in 500 | Carrier Screening |
| MPDU1 | Congenital disorder of glycosylation type If | AR | General Population | <1 in 500 | Carrier Screening |
| MPI | Congenital disorder of glycosylation type Ib | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| MPL | Congenital amegakaryocytic thrombocytopenia | AR | General Population | 1 in 102 | Carrier ScreeningNewborn |
| MPV17 | MPV17-Related Disorders | AR | General Population | <1 in 500 | Carrier Screening |
| MRE11 | Ataxia-Telangiectasia-Like Disorder 1 | AR | General Population | <1 in 500 | Carrier Screening |
| MSH2 | Constitutional mismatch repair deficiency | European (Non-Finnish) Population | 1 in 131 | Cancer Screening | |
| MSH2 | Constitutional mismatch repair deficiency | African / African American Population | 1 in 794 | Cancer Screening | |
| MSH2 | Constitutional mismatch repair deficiency | Ashkenazi Jewish Population | 1 in 832 | Cancer Screening | |
| MSH2 | Constitutional mismatch repair deficiency | East Asian Population | 1 in 1,128 | Cancer Screening | |
| MSH2 | Constitutional mismatch repair deficiency | Latino / Admixed American Population | 1 in 1,230 | Cancer Screening | |
| MSH2 | Constitutional mismatch repair deficiency | Finnish Population | 1 in 2,392 | Cancer Screening | |
| MSH2 | Constitutional mismatch repair deficiency | South Asian Population | 1 in 6,060 | Cancer Screening | |
| MSH3 | No carrier-frequency data published | AR | - | See gene profile → | Cancer Screening |
| MSH6 | Constitutional mismatch repair deficiency | Ashkenazi Jewish Population | 1 in 933 | Cancer Screening | |
| MSH6 | Constitutional mismatch repair deficiency | Finnish Population | 1 in 1,392 | Cancer Screening | |
| MSH6 | Constitutional mismatch repair deficiency | European (Non-Finnish) Population | 1 in 1,649 | Cancer Screening | |
| MSH6 | Constitutional mismatch repair deficiency | East Asian Population | 1 in 1,803 | Cancer Screening | |
| MSH6 | Constitutional mismatch repair deficiency | South Asian Population | 1 in 4,312 | Cancer Screening | |
| MSH6 | Constitutional mismatch repair deficiency | African / African American Population | 1 in 5,138 | Cancer Screening | |
| MSH6 | Constitutional mismatch repair deficiency | Latino / Admixed American Population | 1 in 5,590 | Cancer Screening | |
| MSN | X-linked combined immunodeficiency | XL | General Population | <1 in 50,000 | Carrier Screening |
| MTHFD1 | Combined immunodeficiency and megaloblastic anemia | AR | General Population | <1 in 500 | Carrier Screening |
| MTHFR | Homocystinuria, MTHFR-related | AR | General Population | 1 in 224 | Carrier Screening |
| MTM1 | Myotubular myopathy, X-linked | XL | General Population | 1 in 25,000 | Carrier Screening |
| MTMR2 | Charcot-Marie-Tooth disease, type 4B1 | AR | General Population | <1 in 500 | Carrier Screening |
| MTR | Methylcobalamin deficiency, type cblG | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| MTRR | Homocystinuria-megaloblastic anemia, cobalamin E type | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| MTTP | Abetalipoproteinemia | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| MUSK | MUSK-related conditions | AR | General Population | 1 in 447 | Carrier Screening |
| MUT | Methylmalonic aciduria– methylmalonyl–CoA mutase deficiency | AR | General Population | 1 in 100 | Carrier ScreeningNewborn |
| MUTYH | No carrier-frequency data published | AR | - | See gene profile → | Cancer Screening |
| MVK | Mevalonate kinase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| MYBPC1 | Lethal congenital contractural syndrome 4 | AR | General Population | <1 in 500 | Carrier Screening |
| MYO15A | Nonsyndromic hearing loss, MYO15A-related | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| MYO15A | AR | European (Non-Finnish) Population | 1 in 1,621 | Carrier ScreeningNewborn | |
| MYO15A | AR | Latino / Admixed American Population | 1 in 2,484 | Carrier ScreeningNewborn | |
| MYO15A | AR | African / African American Population | 1 in 5,171 | Carrier ScreeningNewborn | |
| MYO18B | Klippel-Feil anomaly-myopathy- facial dysmorphism syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| MYO7A | MYO7A-related disorders | AR | General Population | 1 in 206 | Carrier Screening |
| MYO7A | Usher syndrome type 1 | AR | European (Non-Finnish) Population | 1 in 950 | Carrier Screening |
| MYO7A | Usher syndrome type 1 | AR | South Asian Population | 1 in 2,291 | Carrier Screening |
| MYO7A | Usher syndrome type 1 | AR | African / African American Population | 1 in 5,180 | Carrier Screening |
| MYO7A | Usher syndrome type 1 | AR | Finnish Population | 1 in 6,662 | Carrier Screening |
| MYO7A | Usher syndrome type 1 | AR | Latino / Admixed American Population | 1 in 9,618 | Carrier Screening |
| NAGA | Schindler disease types 1 and 3 | AR | General Population | 1 in 94 | Carrier Screening |
| NAGLU | Mucopolysaccharidosis type IIIB (Sanfilippo syndrome B) | AR | General Population | <1 in 500 | Carrier Screening |
| NAGS | N-acetylglutamate synthase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| NARS2 | Combined oxidative phosphorylation deficiency, NARS2-related | AR | General Population | <1 in 500 | Carrier Screening |
| NBAS | SOPH syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| NBEAL2 | Gray platelet syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| NBN | Nijmegen breakage syndrome | AR | General Population | 1 in 158 | Carrier Screening |
| NCF1 | No carrier-frequency data published | AR | - | See gene profile → | Carrier Screening |
| NCF2 | Chronic granulomatous disease 2 | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| NCF4 | Chronic granulomatous disease 4 | AR | General Population | <1 in 500 | Carrier Screening |
| NDE1 | Microcephaly with lissencephaly and/or hydranencephaly | AR | General Population | <1 in 500 | Carrier Screening |
| NDP | Norrie disease | XL | General Population | <1 in 50,000 | Carrier Screening |
| NDRG1 | Charcot-Marie-Tooth disease, type 4D | AR | General Population | 1 in 22 | Carrier Screening |
| NDUFA11 | Mitochondrial complex I deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| NDUFAF2 | Mitochondrial complex I deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| NDUFAF5 | Mitochondrial complex I deficiency (Leigh syndrome) | AR | General Population | 1 in 447 | Carrier Screening |
| NDUFAF6 | NDUFAF6-Related Disorders | AR | General Population | <1 in 500 | Carrier Screening |
| NDUFB11 | NDUFB11-related disorders (X-linked) | XL | General Population | <1 in 50,000 | Carrier Screening |
| NDUFS2 | Mitochondrial complex I deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| NDUFS4 | Mitochondrial complex I deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| NDUFS6 | Mitochondrial complex I deficiency (Leigh syndrome) | AR | General Population | <1 in 500 | Carrier Screening |
| NDUFS7 | Mitochondrial complex I deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| NDUFV1 | Mitochondrial complex I deficiency, nuclear type 4 | AR | General Population | <1 in 500 | Carrier Screening |
| NEB | Nemaline myopathy | AR | General Population | 1 in 112 | Carrier Screening |
| NEB | Nemaline myopathy | AR | Latino / Admixed American Population | 1 in 3,191 | Carrier Screening |
| NEB | Nemaline myopathy | AR | European (Non-Finnish) Population | 1 in 4,746 | Carrier Screening |
| NEB | Nemaline myopathy | AR | East Asian Population | 1 in 9,902 | Carrier Screening |
| NEB | Nemaline myopathy | AR | African / African American Population | 1 in 10,359 | Carrier Screening |
| NEK8 | Renal-hepatic-pancreatic dysplasia 2 | AR | General Population | <1 in 500 | Carrier Screening |
| NEU1 | Sialidosis, type I and II | AR | General Population | <1 in 500 | Carrier Screening |
| NF1 | No carrier-frequency data published | AD | - | See gene profile → | Cancer ScreeningNewborn |
| NF2 | No carrier-frequency data published | AD | - | See gene profile → | Newborn |
| NGLY1 | Congenital disorder of deglycosylation | AR | General Population | <1 in 500 | Carrier Screening |
| NHEJ1 | Severe combined immunodeficiency, NHEJ1-related | AR | General Population | <1 in 500 | Carrier Screening |
| NIPAL4 | Autosomal Recessive Congenital Ichthyosis 6 | AR | General Population | <1 in 500 | Carrier Screening |
| NIPBL | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| NONO | X-linked intellectual disability syndrome 34 | XL | General Population | <1 in 50,000 | Carrier Screening |
| NPC1 | Niemann-Pick disease, type C1 | AR | General Population | 1 in 194 | Carrier ScreeningNewborn |
| NPC2 | Niemann-Pick disease, type C2 | AR | General Population | 1 in 194 | Carrier Screening |
| NPHP1 | NPHP1-related ciliopathies | AR | General Population | 1 in 480 | Carrier Screening |
| NPHP3 | NPHP3-related ciliopathies | AR | General Population | <1 in 500 | Carrier Screening |
| NPHP4 | NPHP4-Related Disorders | AR | General Population | <1 in 500 | Carrier Screening |
| NPHS1 | Congenital nephrotic syndrome, type 1 | AR | General Population | 1 in 289 | Carrier Screening |
| NPHS2 | Congenital nephrotic syndrome, type 2 | AR | General Population | 1 in 289 | Carrier Screening |
| NR0B1 | Congenital adrenal hypoplasia, X-linked | XL | General Population | 1 in 6,250 | Carrier ScreeningNewborn |
| NR2E3 | NR2E3-related retinal dystrophies | AR | General Population | 1 in 209 | Carrier Screening |
| NRAS | Congenital melanocytic naevus (giant) | European (Non-Finnish) Population | 1 in 185,305 | KNOVA NIPT | |
| NSD1 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| NSDHL | No carrier-frequency data published | XLD | - | See gene profile → | KNOVA NIPT |
| NSMCE3 | Lung disease, immunodeficiency, and chromosome breakage syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| NTHL1 | No carrier-frequency data published | AR | - | See gene profile → | Cancer Screening |
| NTRK1 | Congenital insensitivity to pain with anhidrosis | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| NUP188 | Sandestig-Stefanova syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| NUP62 | Infantile striatonigral degeneration | AR | General Population | <1 in 500 | Carrier Screening |
| OAT | Gyrate atrophy of choroid and retina | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| OBSL1 | 3M syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| OCA2 | Oculocutaneous albinism type II | AR | General Population | 1 in 76 | Carrier Screening |
| OCRL | OCRL-related disorders | XL | General Population | 1 in 250,000 | Carrier Screening |
| OPA1 | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| OPA3 | Costeff syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| OPHN1 | X-linked intellectual disability- cerebellar hypoplasia syndrome | XL | General Population | <1 in 50,000 | Carrier Screening |
| ORC4 | Meier-Gorlin syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| OSTM1 | Osteopetrosis 5 | AR | General Population | <1 in 500 | Carrier Screening |
| OTC | Ornithine transcarbamylase deficiency | XL | General Population | 1 in 7,000 | Carrier ScreeningNewborn |
| OTOA | Nonsyndromic hearing loss, OTOA-related | AR | General Population | <1 in 500 | Carrier Screening |
| OTOF | Nonsyndromic hearing loss, OTOF-related | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| OTOF | Auditory neuropathy (OTOF) | AR | East Asian Population | 1 in 163 | Carrier ScreeningNewborn |
| OTOF | Auditory neuropathy (OTOF) | AR | Latino / Admixed American Population | 1 in 719 | Carrier ScreeningNewborn |
| OTOF | Auditory neuropathy (OTOF) | AR | African / African American Population | 1 in 3,455 | Carrier ScreeningNewborn |
| OTOF | Auditory neuropathy (OTOF) | AR | South Asian Population | 1 in 21,544 | Carrier ScreeningNewborn |
| OTUD6B | Syndromic intellectual disability, OTUD6B-related | AR | General Population | <1 in 500 | Carrier Screening |
| P3H1 | Osteogenesis imperfecta, type VIII | AR | General Population | <1 in 500 | Carrier Screening |
| PAH | Phenylalanine Hydroxylase deficiency (Phenylketonuria) | AR | General Population | 1 in 93 | Carrier ScreeningNewborn |
| PAH | Phenylketonuria | AR | Ashkenazi Jewish Population | 1 in 18 | Carrier ScreeningNewborn |
| PAH | Phenylketonuria | AR | South Asian Population | 1 in 79 | Carrier ScreeningNewborn |
| PAH | Phenylketonuria | AR | Latino / Admixed American Population | 1 in 104 | Carrier ScreeningNewborn |
| PAH | Phenylketonuria | AR | Finnish Population | 1 in 176 | Carrier ScreeningNewborn |
| PAH | Phenylketonuria | AR | African / African American Population | 1 in 194 | Carrier ScreeningNewborn |
| PAK3 | X-linked intellectual disability, PAK3-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| PALB2 | BRCA1/PALB2-associated breast cancer | Finnish Population | 1 in 287 | Cancer Screening | |
| PALB2 | BRCA1/PALB2-associated breast cancer | European (Non-Finnish) Population | 1 in 1,571 | Cancer Screening | |
| PANK2 | Pantothenate kinase-associated neurodegeneration | AR | General Population | 1 in 289 | Carrier Screening |
| PAX3 | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| PAX7 | Congenital myopathy 19 | AR | General Population | <1 in 500 | Carrier Screening |
| PAX8 | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| PC | Pyruvate carboxylase deficiency | AR | General Population | 1 in 250 | Carrier Screening |
| PCBD1 | Tetrahydrobiopterin deficiency, PCBD1-related | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| PCCA | Propionic acidemia, PCCA-related | AR | General Population | 1 in 224 | Carrier ScreeningNewborn |
| PCCB | Propionic acidemia, PCCB-related | AR | General Population | 1 in 224 | Carrier ScreeningNewborn |
| PCDH12 | Diencephalic-mesencephalic junction dysplasia syndrome 1 | AR | General Population | <1 in 500 | Carrier Screening |
| PCDH15 | PCDH15-related disorders | AR | General Population | 1 in 395 | Carrier Screening |
| PCNT | Microcephalic osteodysplastic primordial dwarfism, type II | AR | General Population | <1 in 500 | Carrier Screening |
| PDE6A | Retinitis pigmentosa, PDE6A-related | AR | General Population | 1 in 133 | Carrier Screening |
| PDE6G | Retinitis pigmentosa 57 | AR | General Population | <1 in 500 | Carrier Screening |
| PDHA1 | No carrier-frequency data published | AR | - | See gene profile | Carrier Screening |
| PDHB | Pyruvate dehydrogenase E1-beta deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| PDHX | Pyruvate dehydrogenase E3-binding protein deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| PDP1 | Pyruvate dehydrogenase phosphatase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| PDX1 | PDX1-related diabetes | AR | General Population | <1 in 500 | Carrier Screening |
| PEPD | Prolidase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| PET100 | Mitochondrial complex IV deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| PEX1 | Zellweger syndrome, PEX1-related | AR | General Population | 1 in 147 | Carrier Screening |
| PEX10 | Zellweger syndrome, PEX10-related | AR | General Population | 1 in 500 | Carrier Screening |
| PEX11B | Zellweger spectrum disorder | AR | General Population | <1 in 500 | Carrier Screening |
| PEX12 | Zellweger syndrome, PEX12-related | AR | General Population | 1 in 373 | Carrier Screening |
| PEX13 | Zellweger spectrum disorder | AR | General Population | <1 in 500 | Carrier Screening |
| PEX14 | Zellweger spectrum disorder | AR | General Population | <1 in 500 | Carrier Screening |
| PEX16 | Zellweger spectrum disorder | AR | General Population | <1 in 500 | Carrier Screening |
| PEX19 | Zellweger spectrum disorder | AR | General Population | <1 in 500 | Carrier Screening |
| PEX2 | Zellweger syndrome, PEX2-related | AR | General Population | 1 in 500 | Carrier Screening |
| PEX26 | Zellweger syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| PEX3 | Zellweger spectrum disorder | AR | General Population | <1 in 500 | Carrier Screening |
| PEX5 | Zellweger spectrum disorder | AR | General Population | <1 in 500 | Carrier Screening |
| PEX6 | Zellweger syndrome, PEX6-related | AR | General Population | 1 in 280 | Carrier Screening |
| PEX7 | Rhizomelic chondrodysplasia punctata, type 1 | AR | General Population | 1 in 158 | Carrier Screening |
| PFKM | Glycogen storage disease VII | AR | General Population | <1 in 500 | Carrier Screening |
| PGAP3 | Hyperphosphatasia with impaired intellectual development syndrome 4 | AR | General Population | <1 in 500 | Carrier Screening |
| PGK1 | Phosphoglycerate kinase 1 deficiency | XL | General Population | <1 in 50,000 | Carrier Screening |
| PGM1 | Congenital disorder of glycosylation type It | AR | General Population | <1 in 500 | Carrier Screening |
| PGM3 | Immunodeficiency 23 | AR | General Population | <1 in 500 | Carrier Screening |
| PHEX | No carrier-frequency data published | AR | - | See gene profile | Newborn |
| PHF8 | X-linked intellectual disability, Siderius type | XL | General Population | <1 in 50,000 | Carrier Screening |
| PHGDH | Phosphoglycerate dehydrogenase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| PHKA1 | Glycogen storage disease type IXd | XL | General Population | <1 in 50,000 | Carrier Screening |
| PHKA2 | Glycogen storage disease type IXa | XL | General Population | <1 in 50,000 | Carrier Screening |
| PHKB | Glycogen storage disease type IXb | AR | General Population | <1 in 500 | Carrier Screening |
| PHKG2 | Glycogen storage disease type IXc | AR | General Population | <1 in 500 | Carrier Screening |
| PHYH | Refsum disease | AR | General Population | <1 in 500 | Carrier Screening |
| PIDD1 | Autosomal recessive intellectual developmental disorder 75 | AR | General Population | <1 in 500 | Carrier Screening |
| PIGA | PIGA-related disorders (X-linked) | XL | General Population | <1 in 50,000 | Carrier Screening |
| PIGN | Multiple congenital anomalies hypotonia seizures syndrome 1 | AR | General Population | <1 in 500 | Carrier Screening |
| PIGQ | Developmental and epileptic encephalopathy 77 | AR | General Population | <1 in 500 | Carrier Screening |
| PIGS | Glycosylphosphatidylinositol biosynthesis defect 18 | AR | General Population | <1 in 500 | Carrier Screening |
| PIGT | Multiple congenital anomalies- hypotonia-seizures syndrome 3 | AR | General Population | <1 in 500 | Carrier Screening |
| PIP5K1C | Lethal congenital contractural syndrome 3 | AR | General Population | <1 in 500 | Carrier Screening |
| PJVK | Nonsyndromic hearing loss 59 | AR | General Population | <1 in 500 | Carrier Screening |
| PKD1 | No carrier-frequency data published | AD | - | See gene profile → | PKD |
| PKD2 | No carrier-frequency data published | AD | - | See gene profile → | PKDNewborn |
| PKHD1 | Polycystic kidney disease, PKHD1-related | AR | General Population | 1 in 70 | Carrier ScreeningPKDNewborn |
| PKLR | Pyruvate kinase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| PLA2G6 | Infantile neuroaxonal dystrophy | AR | General Population | 1 in 500 | Carrier Screening |
| PLAA | Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies | AR | General Population | <1 in 500 | Carrier Screening |
| PLCE1 | Nephrotic Syndrome, PLCE1-Related | AR | General Population | <1 in 500 | Carrier Screening |
| PLD1 | PLD1-related congenital heart disease | AR | General Population | <1 in 500 | Carrier Screening |
| PLEKHG5 | PLEKHG5-related motor neuropathies | AR | General Population | <1 in 500 | Carrier Screening |
| PLOD1 | Ehlers-Danlos syndrome with kyphoscoliosis, PLOD1-related | AR | General Population | 1 in 159 | Carrier Screening |
| PLOD2 | Bruck syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| PLP1 | PLP1-related disorders | XL | General Population | <1 in 50,000 | Carrier Screening |
| PMM2 | PMM2-glycosylation disorders | AR | General Population | 1 in 63 | Carrier Screening |
| PMS2 | Lynch syndrome (PMS2) | European (Non-Finnish) Population | 1 in 907 | Cancer Screening | |
| PMS2 | Lynch syndrome (PMS2) | South Asian Population | 1 in 1,473 | Cancer Screening | |
| PMS2 | Lynch syndrome (PMS2) | Latino / Admixed American Population | 1 in 1,863 | Cancer Screening | |
| PMS2 | Lynch syndrome (PMS2) | African / African American Population | 1 in 2,117 | Cancer Screening | |
| PMS2 | Lynch syndrome (PMS2) | Ashkenazi Jewish Population | 1 in 3,258 | Cancer Screening | |
| PMS2 | Lynch syndrome (PMS2) | East Asian Population | 1 in 4,932 | Cancer Screening | |
| PNP | Purine nucleoside phosphorylase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| PNPLA1 | Autosomal recessive congenital ichthyosis 10 | AR | General Population | <1 in 500 | Carrier Screening |
| PNPO | Pyridoxamine 5’-phosphate oxidase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| POC1A | Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| POLD1 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| POLE | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| POLG | POLG-related disorders | AR | General Population | 1 in 113 | Carrier Screening |
| POLG | Chronic progressive external ophthalmoplegia | AR | East Asian Population | 1 in 4,962 | Carrier Screening |
| POLG | Chronic progressive external ophthalmoplegia | AR | African / African American Population | 1 in 10,359 | Carrier Screening |
| POLG | Chronic progressive external ophthalmoplegia | AR | Latino / Admixed American Population | 1 in 11,181 | Carrier Screening |
| POLG | Chronic progressive external ophthalmoplegia | AR | European (Non-Finnish) Population | 1 in 15,884 | Carrier Screening |
| POLH | Xeroderma pigmentosum | AR | General Population | <1 in 500 | Carrier Screening |
| POLR1C | POLR1C-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| POLR3B | POLR3B-related disorder | AR | General Population | <1 in 500 | Carrier Screening |
| POMGNT1 | POMGNT1 Alpha- dystroglycanopathies | AR | General Population | 1 in 462 | Carrier Screening |
| POMGNT2 | POMGNT2 Alpha- dystroglycanopathies | AR | General Population | 1 in 500 | Carrier Screening |
| POMT1 | POMT1 Alpha- dystroglycanopathies | AR | General Population | 1 in 290 | Carrier Screening |
| POMT2 | POMT2 Alpha- dystroglycanopathies | AR | General Population | 1 in 371 | Carrier Screening |
| POR | Antley-Bixler syndrome | AR | General Population | 1 in 159 | Carrier ScreeningNewborn |
| POU1F1 | Combined pituitary hormone deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| POU3F4 | X-linked hearing loss, POU3F4-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| PPIB | Osteogenesis imperfecta, type IX | AR | General Population | <1 in 500 | Carrier Screening |
| PPP1R13L | Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities | AR | General Population | <1 in 500 | Carrier Screening |
| PPT1 | Neuronal ceroid lipofuscinosis, PPT1-related | AR | General Population | 1 in 368 | Carrier Screening |
| PQBP1 | Renpenning syndrome | XL | General Population | <1 in 500 | Carrier Screening |
| PRCD | Retinitis pigmentosa 36 | AR | General Population | <1 in 500 | Carrier Screening |
| PRDM12 | Hereditary sensory and autonomic neuropathy type VIII | AR | General Population | <1 in 500 | Carrier Screening |
| PRDM5 | Brittle cornea syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| PREPL | Congenital myasthenic syndrome 22 | AR | General Population | <1 in 500 | Carrier Screening |
| PRF1 | Hemophagocytic lymphohistiocytosis, familial, 2 | AR | General Population | 1 in 149 | Carrier ScreeningNewborn |
| PRICKLE1 | Progressive myoclonic epilepsy, type 1B | AR | General Population | <1 in 500 | Carrier Screening |
| PRKDC | PRKDC-related immunodeficiency | AR | General Population | <1 in 500 | Carrier Screening |
| PROP1 | Combined pituitary hormone deficiency 2 | AR | General Population | 1 in 45 | Carrier ScreeningNewborn |
| PRPS1 | No carrier-frequency data published | Various | - | See gene profile | Carrier Screening |
| PRRT2 | No carrier-frequency data published | AR | - | See gene profile | Newborn |
| PSAP | Metachromatic leukodystrophy due to saposin-b deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| PTCH1 | No carrier-frequency data published | AD | - | See gene profile | Newborn |
| PTEN | Cowden syndrome | Finnish Population | 1 in 1,563 | Cancer Screening | |
| PTEN | Cowden syndrome | Latino / Admixed American Population | 1 in 2,110 | Cancer Screening | |
| PTEN | Cowden syndrome | Ashkenazi Jewish Population | 1 in 3,578 | Cancer Screening | |
| PTEN | Cowden syndrome | East Asian Population | 1 in 4,083 | Cancer Screening | |
| PTEN | Cowden syndrome | European (Non-Finnish) Population | 1 in 4,462 | Cancer Screening | |
| PTEN | Cowden syndrome | South Asian Population | 1 in 6,268 | Cancer Screening | |
| PTPN11 | Noonan syndrome | Ashkenazi Jewish Population | 1 in 6,531 | NewbornKNOVA NIPT | |
| PTPN11 | Noonan syndrome | African / African American Population | 1 in 10,333 | NewbornKNOVA NIPT | |
| PTPN11 | Noonan syndrome | European (Non-Finnish) Population | 1 in 11,338 | NewbornKNOVA NIPT | |
| PTPN11 | Noonan syndrome | Finnish Population | 1 in 13,354 | NewbornKNOVA NIPT | |
| PTPN11 | Noonan syndrome | South Asian Population | 1 in 21,561 | NewbornKNOVA NIPT | |
| PTPRC | PTPRC related-severe combined immunodeficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| PTS | Tetrahydrobiopterin deficiency | AR | General Population | 1 in 354 | Carrier ScreeningNewborn |
| PUS1 | Mitochondrial myopathy and sideroblastic anemia 1 | AR | General Population | <1 in 500 | Carrier Screening |
| PYCR1 | Cutis laxa type IIB and type IIIB | AR | General Population | <1 in 500 | Carrier Screening |
| PYGL | Glycogen storage disease VI | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| PYGM | Glycogen storage disease type V | AR | General Population | <1 in 500 | Carrier Screening |
| QDPR | Tetrahydrobiopterin deficiency, QDPR-related | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| RAB23 | Carpenter syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| RAD21 | No carrier-frequency data published | AR | - | See gene profile → | KNOVA NIPT |
| RAD51C | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| RAD51D | No carrier-frequency data published | AD | - | See gene profile | Cancer Screening |
| RAF1 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| RAG1 | Omenn syndrome, RAG1-related | AR | General Population | 1 in 290 | Carrier ScreeningNewborn |
| RAG1 | AR | European (Non-Finnish) Population | 1 in 5,560 | Carrier ScreeningNewborn | |
| RAG1 | AR | South Asian Population | 1 in 10,782 | Carrier ScreeningNewborn | |
| RAG1 | AR | Latino / Admixed American Population | 1 in 11,181 | Carrier ScreeningNewborn | |
| RAG2 | Omenn syndrome, RAG2-related | AR | General Population | 1 in 137 | Carrier ScreeningNewborn |
| RAG2 | AR | South Asian Population | 1 in 1,106 | Carrier ScreeningNewborn | |
| RAG2 | AR | Ashkenazi Jewish Population | 1 in 1,307 | Carrier ScreeningNewborn | |
| RAG2 | AR | European (Non-Finnish) Population | 1 in 2,138 | Carrier ScreeningNewborn | |
| RAG2 | AR | Finnish Population | 1 in 3,338 | Carrier ScreeningNewborn | |
| RAG2 | AR | African / African American Population | 1 in 6,915 | Carrier ScreeningNewborn | |
| RAG2 | AR | Latino / Admixed American Population | 1 in 11,181 | Carrier ScreeningNewborn | |
| RAPSN | RAPSN-associated acetylcholine receptor deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| RARS2 | Pontocerebellar hypoplasia type 6 | AR | General Population | <1 in 500 | Carrier Screening |
| RASGRP1 | Immunodeficiency 64 | AR | General Population | <1 in 500 | Carrier Screening |
| RAX | Microphthalmia, isolated 3 | AR | General Population | 1 in 289 | Carrier Screening |
| RB1 | No carrier-frequency data published | AD | - | See gene profile → | Newborn |
| RBL2 | Brunet-Wagner neurodevelopmental syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| RBM10 | TARP syndrome | XL | General Population | <1 in 50,000 | Carrier Screening |
| RD3 | Leber congenital amaurosis 12 | AR | General Population | <1 in 500 | Carrier Screening |
| RDH12 | Leber congenital amaurosis type 13 | AR | General Population | <1 in 500 | Carrier Screening |
| RDH5 | Fundus albipunctatus | AR | General Population | <1 in 500 | Carrier Screening |
| RECQL4 | RECQL4-related conditions | AR | General Population | <1 in 500 | Carrier Screening |
| RET | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| RFX5 | Bare lymphocyte syndrome type II | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| RFXANK | MHC class II deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| RFXAP | Bare lymphocyte syndrome type II | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| RHAG | Rh Deficiency syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| RIT1 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| RLBP1 | Retinal dystrophy, RLBP1-related | AR | General Population | 1 in 296 | Carrier Screening |
| RMRP | Cartilage-Hair Hypoplasia Anauxetic Dysplasia Spectrum Disorder | AR | General Population | <1 in 500 | Carrier Screening |
| RMRP | AR | Latino / Admixed American Population | 1 in 349 | Carrier Screening | |
| RMRP | AR | East Asian Population | 1 in 355 | Carrier Screening | |
| RMRP | AR | Finnish Population | 1 in 865 | Carrier Screening | |
| RMRP | AR | European (Non-Finnish) Population | 1 in 1,516 | Carrier Screening | |
| RMRP | AR | African / African American Population | 1 in 2,807 | Carrier Screening | |
| RMRP | AR | South Asian Population | 1 in 3,482 | Carrier Screening | |
| RNASEH2A | Aicardi-Goutieres syndrome 4 | AR | General Population | <1 in 500 | Carrier Screening |
| RNASEH2B | Aicardi Goutieres syndrome 2 | AR | General Population | 1 in 217 | Carrier Screening |
| RNASEH2C | Aicardi-Goutieres syndrome 3 | AR | General Population | <1 in 500 | Carrier Screening |
| RNF43 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| ROGDI | Kohlschutter-Tonz syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| RP2 | X-linked Retinitis pigmentosa, RP2-related | XL | General Population | 1 in 4,000 | Carrier Screening |
| RPE65 | RPE65-related retinopathy | AR | General Population | 1 in 228 | Carrier Screening |
| RPE65 | Leber congenital amaurosis (RPE65) | AR | African / African American Population | 1 in 242 | Carrier Screening |
| RPE65 | Leber congenital amaurosis (RPE65) | AR | Latino / Admixed American Population | 1 in 430 | Carrier Screening |
| RPE65 | Leber congenital amaurosis (RPE65) | AR | European (Non-Finnish) Population | 1 in 492 | Carrier Screening |
| RPE65 | Leber congenital amaurosis (RPE65) | AR | East Asian Population | 1 in 536 | Carrier Screening |
| RPE65 | Leber congenital amaurosis (RPE65) | AR | South Asian Population | 1 in 937 | Carrier Screening |
| RPE65 | Leber congenital amaurosis (RPE65) | AR | Finnish Population | 1 in 2,968 | Carrier Screening |
| RPE65 | Leber congenital amaurosis (RPE65) | AR | Ashkenazi Jewish Population | 1 in 4,356 | Carrier Screening |
| RPGR | X-linked RPGR-related retinopathy | XL | General Population | 1 in 3,000 | Carrier Screening |
| RPGR | Retinitis pigmentosa (multiple) | XL | European (Non-Finnish) Population | 1 in 28,023 | Carrier Screening |
| RPGRIP1 | Leber congenital amaurosis and Cone-rod dystrophy | AR | General Population | <1 in 500 | Carrier Screening |
| RPGRIP1L | RPGRIP1L-related ciliopathies | AR | General Population | 1 in 259 | Carrier Screening |
| RPL10 | X-linked intellectual disability, RPL10-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| RPS6KA3 | Coffin-Lowry syndrome | XL | General Population | 1 in 66,700 | Carrier Screening |
| RS1 | Juvenile retinoschisis, X-linked | XL | General Population | 1 in 2,500 | Carrier Screening |
| RS1 | X-linked juvenile retinoschisis | XL | Finnish Population | 1 in 10,133 | Carrier Screening |
| RS1 | X-linked juvenile retinoschisis | XL | European (Non-Finnish) Population | 1 in 16,191 | Carrier Screening |
| RSPH9 | Primary ciliary dyskinesia 12 | AR | General Population | <1 in 500 | Carrier Screening |
| RTEL1 | Dyskeratosis congenita type 5 | AR | General Population | 1 in 500 | Carrier Screening |
| RUNX2 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| RXYLT1 | Congenital muscular dystrophy- dystroglycanopathy with brain and eye anomalies (type A) | AR | General Population | <1 in 500 | Carrier Screening |
| RYR1 | Malignant hyperthermia and other RYR1-related myopathies | AR | General Population | <1 in 500 | Carrier Screening |
| RYR1 | Malignant hyperthermia susceptibility | European (Non-Finnish) Population | 1 in 643 | Carrier Screening | |
| RYR1 | Malignant hyperthermia susceptibility | African / African American Population | 1 in 1,093 | Carrier Screening | |
| RYR1 | Malignant hyperthermia susceptibility | South Asian Population | 1 in 1,724 | Carrier Screening | |
| RYR1 | Malignant hyperthermia susceptibility | Latino / Admixed American Population | 1 in 1,863 | Carrier Screening | |
| RYR1 | Malignant hyperthermia susceptibility | Finnish Population | 1 in 2,047 | Carrier Screening | |
| RYR1 | Malignant hyperthermia susceptibility | East Asian Population | 1 in 9,925 | Carrier Screening | |
| SACS | Autosomal recessive spastic ataxia of Charlevoix-Saguenay | AR | General Population | <1 in 500 | Carrier Screening |
| SAG | Retinitis pigmentosa 47 | AR | General Population | 1 in 228 | Carrier Screening |
| SAMD9 | SAMD9-related conditions | AR | General Population | <1 in 500 | Carrier Screening |
| SAMHD1 | Aicardi-Goutieres syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SARS2 | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SASH3 | X-linked combined immunodeficiency | XL | General Population | <1 in 50,000 | Carrier Screening |
| SBDS | Shwachman-Diamond syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SCAPER | Intellectual developmental disorder and retinitis pigmentosa | AR | General Population | <1 in 500 | Carrier Screening |
| SCARB2 | Action Myoclonus-Renal Failure Syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SCN1A | Dravet syndrome | AR | African / African American Population | 1 in 10,343 | Newborn |
| SCN1A | Dravet syndrome | AR | South Asian Population | 1 in 21,559 | Newborn |
| SCN1A | Dravet syndrome | AR | European (Non-Finnish) Population | 1 in 138,872 | Newborn |
| SCN2A | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| SCN8A | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| SCN9A | SCN9A-related conditions | AR | General Population | <1 in 500 | Carrier Screening |
| SCNN1A | No carrier-frequency data published | AR | - | See gene profile | Newborn |
| SCNN1B | No carrier-frequency data published | AR | - | See gene profile | Newborn |
| SCO1 | Mitochondrial complex IV deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| SCO2 | Mitochondrial complex IV deficiency | AR | General Population | 1 in 150 | Carrier Screening |
| SDCCAG8 | Bardet-Biedl syndrome and Senior- Loken syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SDHA | Mitochondrial complex II deficiency | AR | General Population | <1 in 500 | Carrier ScreeningCancer Screening |
| SDHB | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| SDHC | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| SDHD | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| SDR9C7 | Autosomal recessive congenital ichthyosis | AR | General Population | <1 in 500 | Carrier Screening |
| SEC23B | Congenital dyserythropoietic anemia, type II | AR | General Population | <1 in 500 | Carrier Screening |
| SELENOI | Spastic paraplegia 81 | AR | General Population | <1 in 500 | Carrier Screening |
| SELENON | Rigid spine muscular dystrophy | AR | General Population | <1 in 500 | Carrier Screening |
| SEPSECS | Pontocerebellar hypoplasia type 2D | AR | General Population | <1 in 500 | Carrier Screening |
| SERPINA1 | Alpha-1 antitrypsin deficiency | AR | General Population | 1 in 33 | Carrier Screening |
| SERPINA1 | Alpha-1 antitrypsin deficiency (liver) | AR | Latino / Admixed American Population | 1 in 15 | Carrier Screening |
| SERPINA1 | Alpha-1 antitrypsin deficiency (liver) | AR | Ashkenazi Jewish Population | 1 in 29 | Carrier Screening |
| SERPINA1 | Alpha-1 antitrypsin deficiency (liver) | AR | African / African American Population | 1 in 51 | Carrier Screening |
| SERPINA1 | Alpha-1 antitrypsin deficiency (liver) | AR | Finnish Population | 1 in 59 | Carrier Screening |
| SERPINA1 | Alpha-1 antitrypsin deficiency (liver) | AR | Middle Eastern Population | 1 in 78 | Carrier Screening |
| SERPINA1 | Alpha-1 antitrypsin deficiency (liver) | AR | East Asian Population | 1 in 535 | Carrier Screening |
| SERPINA1 | Alpha-1 antitrypsin deficiency (liver) | AR | South Asian Population | 1 in 2,270 | Carrier Screening |
| SERPINF1 | Osteogenesis imperfecta, type VI | AR | General Population | <1 in 500 | Carrier Screening |
| SGCA | Limb-girdle muscular dystrophy, type 2D | AR | General Population | <1 in 500 | Carrier Screening |
| SGCA | AR | Ashkenazi Jewish Population | 1 in 653 | Carrier Screening | |
| SGCA | AR | Latino / Admixed American Population | 1 in 658 | Carrier Screening | |
| SGCA | AR | South Asian Population | 1 in 863 | Carrier Screening | |
| SGCA | AR | Middle Eastern Population | 1 in 961 | Carrier Screening | |
| SGCA | AR | East Asian Population | 1 in 3,970 | Carrier Screening | |
| SGCA | AR | African / African American Population | 1 in 5,194 | Carrier Screening | |
| SGCB | Limb-girdle muscular dystrophy, type 2E | AR | General Population | 1 in 500 | Carrier Screening |
| SGCB | AR | South Asian Population | 1 in 4,792 | Carrier Screening | |
| SGCB | AR | African / African American Population | 1 in 8,369 | Carrier Screening | |
| SGCB | AR | European (Non-Finnish) Population | 1 in 20,587 | Carrier Screening | |
| SGCD | Limb-girdle muscular dystrophy, type 2F | AR | General Population | <1 in 500 | Carrier Screening |
| SGCD | AR | African / African American Population | 1 in 10,389 | Carrier Screening | |
| SGCD | AR | European (Non-Finnish) Population | 1 in 69,391 | Carrier Screening | |
| SGCG | Limb-girdle muscular dystrophy, type 2C | AR | General Population | 1 in 381 | Carrier Screening |
| SGCG | AR | Latino / Admixed American Population | 1 in 7,454 | Carrier Screening | |
| SGSH | Mucopolysaccharidosis IIIA (Sanfilippo syndrome A) | AR | General Population | 1 in 454 | Carrier Screening |
| SGSM3 | SGSM3-Related Intellectual Disability | AR | General Population | < 1 in 500 | Carrier Screening |
| SH3TC2 | Charcot-Marie-Tooth disease, SH3TC2-related | AR | General Population | 1 in 69 | Carrier Screening |
| SHOC2 | European (Non-Finnish) Population | 1 in 138,937 | KNOVA NIPT | ||
| SKI | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| SKIV2L | Trichohepatoenteric syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| SLC12A1 | Bartter syndrome, type 1 | AR | General Population | <1 in 500 | Carrier Screening |
| SLC12A3 | Gitelman syndrome | AR | General Population | 1 in 100 | Carrier Screening |
| SLC12A6 | Andermann syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SLC16A2 | Allan-Herndon-Dudley syndrome | XL | General Population | <1 in 500 | Carrier Screening |
| SLC17A5 | Sialic acid storage disorder | AR | General Population | <1 in 500 | Carrier Screening |
| SLC18A3 | Congenital myasthenic syndrome 21 | AR | General Population | <1 in 500 | Carrier Screening |
| SLC19A2 | Thiamine-responsive megaloblastic anemia syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SLC19A3 | Biotin-responsive basal ganglia disease | AR | General Population | 1 in 109 | Carrier Screening |
| SLC1A4 | Spastic tetraplegia, thin corpus callosum, and progressive microcephaly syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SLC22A5 | Systemic primary carnitine deficiency | AR | General Population | 1 in 129 | Carrier ScreeningNewborn |
| SLC25A13 | Citrin deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SLC25A15 | Hyperornithinemia- hyperammonemia- homocitrullinemia syndrome (Triple H syndrome) | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SLC25A20 | Carnitine-acylcarnitine translocase deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SLC25A24 | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| SLC26A2 | SLC26A2-related disorders | AR | General Population | 1 in 158 | Carrier Screening |
| SLC26A3 | Congenital secretory chloride diarrhea | AR | General Population | <1 in 500 | Carrier Screening |
| SLC26A4 | Pendred syndrome | AR | General Population | 1 in 80 | Carrier ScreeningNewborn |
| SLC26A4 | DFNB4/Enlarged vestibular aqueduct | AR | Ashkenazi Jewish Population | 1 in 70 | Carrier ScreeningNewborn |
| SLC26A4 | DFNB4/Enlarged vestibular aqueduct | AR | South Asian Population | 1 in 128 | Carrier ScreeningNewborn |
| SLC26A4 | DFNB4/Enlarged vestibular aqueduct | AR | East Asian Population | 1 in 161 | Carrier ScreeningNewborn |
| SLC26A4 | DFNB4/Enlarged vestibular aqueduct | AR | European (Non-Finnish) Population | 1 in 215 | Carrier ScreeningNewborn |
| SLC26A4 | DFNB4/Enlarged vestibular aqueduct | AR | Latino / Admixed American Population | 1 in 639 | Carrier ScreeningNewborn |
| SLC26A4 | DFNB4/Enlarged vestibular aqueduct | AR | Finnish Population | 1 in 1,213 | Carrier ScreeningNewborn |
| SLC26A4 | DFNB4/Enlarged vestibular aqueduct | AR | Middle Eastern Population | 1 in 1,441 | Carrier ScreeningNewborn |
| SLC26A4 | DFNB4/Enlarged vestibular aqueduct | AR | African / African American Population | 1 in 2,595 | Carrier ScreeningNewborn |
| SLC27A4 | Ichthyosis prematurity syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SLC29A3 | Histiocytosis-lymphadenopathy plus syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SLC2A1 | No carrier-frequency data published | AR | - | See gene profile | Newborn |
| SLC2A10 | Arterial tortuosity syndrome | AR | General Population | 1 in 300 | Carrier Screening |
| SLC2A2 | Fanconi-Bickel syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SLC30A9 | Birk-Landau-Perez syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SLC34A3 | Hereditary hypophosphatemic rickets with hypercalciuria | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SLC35A2 | Congenital disorder of glycosylation type IIm | XL | General Population | <1 in 50,000 | Carrier Screening |
| SLC35A3 | Arthrogryposis, intellectual disability, and seizures | AR | General Population | <1 in 500 | Carrier Screening |
| SLC37A4 | Glycogen storage disease, type Ib | AR | General Population | 1 in 158 | Carrier ScreeningNewborn |
| SLC38A8 | Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis | AR | General Population | <1 in 500 | Carrier Screening |
| SLC39A4 | Acrodermatitis enteropathica | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SLC3A1 | Cystinuria, type I | AR | General Population | 1 in 50 | Carrier Screening |
| SLC45A2 | Oculocutaneous albinism, type IV | AR | General Population | 1 in 159 | Carrier ScreeningNewborn |
| SLC46A1 | Hereditary folate malabsorption | AR | General Population | <1 in 500 | Carrier Screening |
| SLC4A1 | Distal Renal Tubular Acidosis | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SLC4A11 | Corneal endothelial dystrophy | AR | General Population | <1 in 500 | Carrier Screening |
| SLC4A4 | Proximal Renal Tubular Acidosis- Ocular Anomaly Syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SLC5A5 | Thyroid dyshormonogenesis, SLC5A5-related | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SLC6A19 | Hartnup disorder | AR | General Population | 1 in 87 | Carrier Screening |
| SLC6A8 | Creatine deficiency syndrome | XL | General Population | 1 in 3,434 | Carrier Screening |
| SLC6A9 | Atypical glycine encephalopathy | AR | General Population | <1 in 500 | Carrier Screening |
| SLC7A7 | Lysinuric protein intolerance | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SLC7A9 | Cystinuria, non-type I | AR | General Population | 1 in 42 | Carrier Screening |
| SLCO1B1 | No carrier-frequency data published | Polygenic | - | See gene profile → | pgx |
| SMAD3 | No carrier-frequency data published | AD | - | See gene profile → | Newborn |
| SMAD4 | No carrier-frequency data published | AD | - | See gene profile → | Cancer ScreeningNewborn |
| SMARCAL1 | Schimke immunoosseous dysplasia | AR | General Population | 1 in 500 | Carrier Screening |
| SMC1A | No carrier-frequency data published | XLD | - | See gene profile → | KNOVA NIPT |
| SMC3 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| SMN1 | Spinal muscular atrophy | AR | General Population | 1 in 54 | Carrier ScreeningNewborn |
| SMN1 | Spinal muscular atrophy silent carrier | AR | General Population | 1 in 54 | Carrier ScreeningNewborn |
| SMPD1 | Niemann-Pick disease, type A/B | AR | General Population | 1 in 250 | Carrier ScreeningNewborn |
| SNAP29 | Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SNRPB | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| SNX10 | Osteopetrosis 8 | AR | General Population | <1 in 500 | Carrier Screening |
| SOS1 | Noonan syndrome | European (Non-Finnish) Population | 1 in 50,531 | KNOVA NIPT | |
| SOS2 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| SOX10 | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| SOX9 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| SP110 | Hepatic venoocclusive disease with immunodeficiency | AR | General Population | <1 in 500 | Carrier Screening |
| SPATA5 | Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities | AR | General Population | <1 in 500 | |
| SPATA7 | Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (RP) | AR | General Population | <1 in 500 | Carrier Screening |
| SPECC1L | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| SPEG | Centronuclear myopathy 5 | AR | General Population | <1 in 500 | Carrier Screening |
| SPG11 | SPG11-related Neuromuscular Disorders | AR | General Population | 1 in 159 | Carrier Screening |
| SPG21 | Mast syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| SPG7 | Spastic paraplegia type 7 | AR | General Population | 1 in 159 | Carrier Screening |
| SPINK5 | Netherton syndrome | AR | General Population | 1 in 224 | Carrier Screening |
| SPR | Sepiapterin Reductase Deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SPTB | No carrier-frequency data published | AR | - | See gene profile | Newborn |
| SRD5A2 | 5-alpha reductase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| ST3GAL5 | Salt and pepper developmental regression syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| STAR | Lipoid congenital adrenal hyperplasia | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| STAT1 | Immunodeficiency 31B | AR | General Population | <1 in 500 | Carrier Screening |
| STAT3 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| STK11 | No carrier-frequency data published | AD | - | See gene profile → | Cancer ScreeningNewborn |
| STK4 | Combined immunodeficiency due to STK4 deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| STS | X-linked ichthyosis | XL | General Population | 1 in 1250 | Carrier Screening |
| STX11 | Familial hemophagocytic lymphohistiocytosis | AR | General Population | 1 in 112 | Carrier Screening |
| STXBP2 | Familial hemophagocytic lymphohistiocytosis | AR | General Population | 1 in 112 | Carrier Screening |
| SUCLA2 | Mitochondrial DNA depletion syndrome 5 | AR | General Population | <1 in 500 | Carrier Screening |
| SUMF1 | Multiple sulfatase deficiency | AR | General Population | 1 in 500 | Carrier Screening |
| SUOX | Sulfite oxidase deficiency | AR | General Population | 1 in 300 | Carrier Screening |
| SURF1 | Leigh syndrome, SURF1-related | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| SYN1 | X-linked epilepsy with variable learning disabilities | XL | General Population | <1 in 50,000 | Carrier Screening |
| SYNE4 | Autosomal recessive deafness 76 | AR | General Population | <1 in 500 | Carrier Screening |
| SZT2 | Developmental and epileptic encephalopathy 18 | AR | General Population | < 1 in 500 | Carrier Screening |
| TAF2 | TAF2-related intellectual disability | AR | General Population | <1 in 500 | Carrier Screening |
| TANGO2 | Metabolic crises with rhabdomyolysis, cardiac arrhythmias and neurodegeneration | AR | General Population | <1 in 500 | Carrier Screening |
| TAT | Tyrosinemia, type II | AR | General Population | 1 in 250 | Carrier ScreeningNewborn |
| TAZ | Barth syndrome | XL | General Population | <1 in 50,000 | Carrier ScreeningNewborn |
| TBCB | No carrier-frequency data published | - | See gene profile | Carrier Screening | |
| TBCD | Encephalopathy, progressive, early- onset, with brain atrophy and thin corpus callosum | AR | General Population | <1 in 500 | Carrier Screening |
| TBCE | TBCE-related conditions | AR | General Population | <1 in 500 | Carrier Screening |
| TBX19 | Adrenocorticotropic hormone deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| TCF12 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| TCIRG1 | Osteopetrosis 1 | AR | General Population | 1 in 250 | Carrier ScreeningNewborn |
| TCN2 | Transcobalamin II deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| TCTN1 | Joubert syndrome 13 | AR | General Population | <1 in 500 | Carrier Screening |
| TCTN2 | TCTN2-related ciliopathies | AR | General Population | <1 in 500 | Carrier Screening |
| TCTN3 | Joubert syndrome 18 | AR | General Population | <1 in 500 | Carrier Screening |
| TECPR2 | Spastic paraplegia 49 | AR | General Population | <1 in 500 | Carrier Screening |
| TECRL | Catecholaminergic polymorphic ventricular tachycardia 3 | AR | General Population | <1 in 500 | Carrier Screening |
| TECTA | AR | European (Non-Finnish) Population | 1 in 2,059 | Newborn | |
| TECTA | AR | African / African American Population | 1 in 10,368 | Newborn | |
| TERT | Dyskeratosis congenita type 4 | AR | General Population | <1 in 500 | Carrier Screening |
| TF | Atransferrinemia | AR | General Population | 1 in 116 | Carrier Screening |
| TFE3 | X-linked intellectual disability, TFE3-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| TFR2 | Hemochromatosis, type 3 | AR | General Population | <1 in 500 | Carrier Screening |
| TFRC | Immunodeficiency 46 | AR | General Population | <1 in 500 | Carrier Screening |
| TG | Thyroid dyshormonogenesis, TG-related | AR | General Population | 1 in 241 | Carrier ScreeningNewborn |
| TGFBR1 | No carrier-frequency data published | AD | - | See gene profile → | Newborn |
| TGFBR2 | No carrier-frequency data published | AD | - | See gene profile → | Newborn |
| TGM1 | Congenital ichthyosis | AR | General Population | 1 in 224 | Carrier Screening |
| TH | Segawa syndrome | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| THG1L | Spinocerebellar ataxia 28 | AR | General Population | < 1 in 500 | Carrier Screening |
| THOC2 | X-linked Intellectual disability, THOC2-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| THRA | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| TIMM50 | 3-methylglutaconic aciduria type IX | AR | General Population | <1 in 500 | Carrier Screening |
| TJP2 | TJP2-Related Disorders | AR | General Population | <1 in 500 | Carrier Screening |
| TK2 | Mitochondrial DNA depletion syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| TKT | Short stature, developmental delay, and congenital heart defects | AR | General Population | < 1 in 500 | Carrier Screening |
| TMC1 | Nonsyndromic hearing loss 7 | AR | General Population | <1 in 500 | Carrier Screening |
| TMEM107 | TMEM107-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| TMEM127 | No carrier-frequency data published | AD | - | See gene profile → | Cancer Screening |
| TMEM138 | Joubert syndrome 16 | AR | General Population | <1 in 500 | Carrier Screening |
| TMEM216 | TMEM216-related ciliopathies | AR | General Population | 1 in 141 | Carrier Screening |
| TMEM231 | Joubert syndrome 20 | AR | General Population | <1 in 500 | Carrier Screening |
| TMEM237 | Joubert syndrome 14 | AR | General Population | <1 in 500 | Carrier Screening |
| TMEM38B | Osteogenesis imperfecta, type XIV | AR | General Population | <1 in 500 | Carrier Screening |
| TMEM67 | COACH syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| TMEM70 | Mitochondrial complex V deficiency type 2 | AR | General Population | <1 in 500 | Carrier Screening |
| TMEM94 | Intellectual developmental disorder with cardiac defects and dysmorphic facies | AR | General Population | <1 in 500 | Carrier Screening |
| TMIE | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| TMPRSS3 | Nonsyndromic hearing loss, TMPRSS3-related | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| TNFRSF9 | Immunodeficiency 109 with lymphoproliferation | AR | General Population | <1 in 500 | Carrier Screening |
| TNFSF11 | Osteopetrosis 2 | AR | General Population | 1 in 250 | Carrier Screening |
| TNNT1 | Nemaline myopathy 5 | AR | General Population | <1 in 500 | Carrier Screening |
| TNR | Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus | AR | General Population | <1 in 500 | Carrier Screening |
| TNXB | Ehlers–Danlos-like syndrome due to tenascin-X deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| TP53 | Li-Fraumeni syndrome | Ashkenazi Jewish Population | 1 in 6,534 | Cancer Screening | |
| TP53 | Li-Fraumeni syndrome | European (Non-Finnish) Population | 1 in 9,928 | Cancer Screening | |
| TPMT | No carrier-frequency data published | AD | - | See gene profile | pgx |
| TPO | Thyroid dyshormonogenesis, TPO-related | AR | General Population | 1 in 373 | Carrier ScreeningNewborn |
| TPP1 | Neuronal ceroid lipofuscinosis, TPP1-related | AR | General Population | 1 in 252 | Carrier Screening |
| TPRN | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| TRAF3IP1 | Senior-Loken syndrome 9 | AR | General Population | <1 in 500 | |
| TRAF7 | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| TRAPPC11 | Limb-girdle muscular dystrophy 18 | AR | General Population | <1 in 500 | Carrier Screening |
| TRAPPC6B | Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy | AR | General Population | <1 in 500 | Carrier Screening |
| TRDN | Catecholaminergic polymorphic ventricular tachycardia | AR | General Population | 1 in 354 | Carrier Screening |
| TREX1 | Aicardi-Goutieres syndrome 1 | AR | General Population | <1 in 500 | Carrier Screening |
| TRHR | Generalized thyrotropin-releasing hormone resistance | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| TRIM32 | TRIM32-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| TRIM37 | Mulibrey nanism | AR | General Population | <1 in 500 | Carrier Screening |
| TRIOBP | No carrier-frequency data published | Various | - | See gene profile | Newborn |
| TRIP11 | TRIP11-related skeletal dysplasia | AR | General Population | <1 in 500 | Carrier Screening |
| TRMU | Liver failure, acute infantile | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| TRPM6 | Hypomagnesemia 1 | AR | General Population | <1 in 500 | Carrier Screening |
| TSC1 | No carrier-frequency data published | AD | - | See gene profile → | Cancer ScreeningNewbornKNOVA NIPT |
| TSC2 | No carrier-frequency data published | AD | - | See gene profile → | Cancer ScreeningNewbornKNOVA NIPT |
| TSEN2 | Pontocerebellar hypoplasia type 2B | AR | General Population | <1 in 500 | Carrier Screening |
| TSEN34 | Pontocerebellar hypoplasia type 2C | AR | General Population | <1 in 500 | Carrier Screening |
| TSEN54 | Pontocerebellar hypoplasia type 2A | AR | General Population | 1 in 250 | Carrier Screening |
| TSFM | Combined oxidative phosphorylation deficiency, TSFM-related | AR | General Population | <1 in 500 | Carrier Screening |
| TSHB | Congenital hypothyroidism, TSHB-related | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| TSHR | Congenital hypothyroidism, TSHR-related | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| TSPEAR | Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis | AR | General Population | 1 in 140 | Carrier Screening |
| TTC37 | Trichohepatoenteric syndrome | AR | General Population | 1 in 500 | Carrier Screening |
| TTC7A | Gastrointestinal defects and immunodeficiency syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| TTC8 | Bardet-Biedl syndrome 8 | AR | General Population | <1 in 500 | Carrier Screening |
| TTN | TTN-related conditions AD, | AR | General Population | <1 in 500 | Carrier Screening |
| TTPA | Ataxia with isolated vitamin E deficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| TULP1 | TULP1-related retinal disorders | AR | General Population | <1 in 500 | Carrier Screening |
| TWIST1 | No carrier-frequency data published | AD | - | See gene profile → | KNOVA NIPT |
| TWNK | Mitochondrial DNA depletion syndrome 7 | AR | General Population | <1 in 500 | Carrier Screening |
| TYMP | Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease | AR | General Population | <1 in 500 | Carrier Screening |
| TYR | Oculocutaneous albinism types 1A and 1B | AR | General Population | 1 in 100 | Carrier Screening |
| TYRP1 | Oculocutaneous albinism, type III | AR | General Population | <1 in 500 | Carrier Screening |
| UBA1 | UBA1-Related Spinal Muscular Atrophy, X-Linked Infantile | XL | General Population | 1 in 750,000 | Carrier Screening |
| UBR1 | Johanson-Blizzard syndrome | AR | General Population | 1 in 250 | Carrier Screening |
| UGT1A1 | Crigler-Najjar syndrome | AR | General Population | <1 in 500 | Carrier ScreeningNewbornpgx |
| UNC13D | Familial hemophagocytic lymphohistiocytosis type 3 | AR | General Population | 1 in 149 | Carrier Screening |
| UNC80 | Hypotonia, infantile, with psychomotor impairment and characteristic facies 2 | AR | General Population | <1 in 500 | Carrier Screening |
| UNG | Immunodeficiency with Hyper IgM syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| UPB1 | Beta-ureidopropionase deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| UPF3B | Lujan-Fryns syndrome, UPF3B-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| UQCRQ | Mitochondrial complex III deficiency | AR | General Population | <1 in 500 | Carrier Screening |
| USH1C | USH1C-related disorders | AR | General Population | 1 in 353 | Carrier ScreeningNewborn |
| USH1G | Usher syndrome type IG | AR | General Population | 1 in 434 | Carrier ScreeningNewborn |
| USH2A | Usher syndrome, type 2A | AR | General Population | 1 in 126 | Carrier ScreeningNewborn |
| USH2A | Retinitis pigmentosa (multiple) | AR | Latino / Admixed American Population | 1 in 230 | Carrier ScreeningNewborn |
| USH2A | Retinitis pigmentosa (multiple) | AR | South Asian Population | 1 in 599 | Carrier ScreeningNewborn |
| USH2A | Retinitis pigmentosa (multiple) | AR | African / African American Population | 1 in 649 | Carrier ScreeningNewborn |
| USH2A | Retinitis pigmentosa (multiple) | AR | East Asian Population | 1 in 1,240 | Carrier ScreeningNewborn |
| USP9X | X-linked intellectual disability, USP9X-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| VDR | Vitamin D-dependent rickets, type 2A | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| VHL | No carrier-frequency data published | AD | - | See gene profile → | Cancer ScreeningNewborn |
| VLDLR | Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1 | AR | General Population | <1 in 500 | Carrier Screening |
| VPS11 | Hypomyelinating leukodystrophy-12 | AR | General Population | <1 in 500 | Carrier Screening |
| VPS13A | Choreoacanthocytosis | AR | General Population | <1 in 500 | Carrier Screening |
| VPS13B | Cohen syndrome | AR | General Population | <1 in 500 | Carrier Screening |
| VPS37A | Spastic paraplegia 53 | AR | General Population | <1 in 500 | Carrier Screening |
| VPS45 | Severe congenital neutropenia, VPS45-related | AR | General Population | 1 in 224 | Carrier Screening |
| VPS53 | Pontocerebellar hypoplasia type 2E | AR | General Population | <1 in 500 | Carrier Screening |
| VRK1 | Pontocerebellar hypoplasia type 1A | AR | General Population | <1 in 500 | Carrier Screening |
| VSX2 | Microphthalmia with or without coloboma | AR | General Population | 1 in 91 | Carrier Screening |
| WAS | WAS-related hematopoietic disorder | XL | General Population | 1 in 125,000 | Carrier Screening |
| WDPCP | Bardet-Biedl syndrome 15 | AR | General Population | <1 in 500 | Carrier Screening |
| WDR34 | Short-rib thoracic dysplasia 11 with or without polydactyly | AR | General Population | <1 in 500 | Carrier Screening |
| WDR62 | Microcephaly 2, primary, autosomal recessive, with or without cortical malformations | AR | General Population | <1 in 500 | Carrier Screening |
| WHRN | Usher syndrome type 2D | AR | General Population | 1 in 282 | Carrier ScreeningNewborn |
| WISP3 | Progressive pseudorheumatoid dysplasia | AR | General Population | <1 in 500 | Carrier Screening |
| WNT1 | Osteogenesis imperfecta type 15 | AR | General Population | <1 in 500 | Carrier Screening |
| WNT10A | WNT10A-related ectodermal dysplasias | AR | General Population | <1 in 500 | Carrier Screening |
| WRN | Werner syndrome | AR | General Population | 1 in 308 | Carrier Screening |
| WT1 | No carrier-frequency data published | AD | - | See gene profile → | Newborn |
| WWOX | WWOX-related disorders | AR | General Population | <1 in 500 | Carrier Screening |
| XPA | Xeroderma pigmentosum, group A | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| XPC | Xeroderma pigmentosum, group C | AR | General Population | 1 in 500 | Carrier ScreeningNewborn |
| XRCC2 | Fanconi anemia group U | AR | General Population | <1 in 500 | Carrier Screening |
| YARS | Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2 | AR | General Population | <1 in 500 | |
| ZAP70 | ZAP70-related Immunodeficiency | AR | General Population | <1 in 500 | Carrier ScreeningNewborn |
| ZBTB24 | Immunodeficiency-centromeric instability-facial anomalies syndrome 2 | AR | General Population | <1 in 500 | Carrier Screening |
| ZDHHC9 | X-linked intellectual disability, ZDHHC9-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| ZFYVE26 | Spastic paraplegia 15 | AR | General Population | <1 in 500 | Carrier Screening |
| ZIC1 | No carrier-frequency data published | - | See gene profile → | KNOVA NIPT | |
| ZIC3 | ZIC3-Related Disorders | XL | General Population | 1 in 750,000 | Carrier ScreeningNewborn |
| ZNF341 | Hyper-IgE syndrome 3 | AR | General Population | <1 in 500 | Carrier Screening |
| ZNF469 | Brittle cornea syndrome 1 | AR | General Population | <1 in 500 | Carrier Screening |
| ZNF711 | X-linked intellectual disability, ZNF711-related | XL | General Population | <1 in 50,000 | Carrier Screening |
| ZNHIT3 | PEHO syndrome | AR | General Population | <1 in 500 | Carrier Screening |
No matching rows. Try clearing one of the filters.